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The practice of anaesthesia, potentially a highly
scientific branch of modern medicine, affords continual
stimulation to the clinical anaesthetist interested in
applied pharmacology. It is an understatement to assert
that a close association between the pharmacologist and
the anaesthetist is desirable. The studies to be des¬
cribed in this thesis may appear to have little direct
connection with the pharmacology of anaesthetic drugs;
they were performed, however, in the course of a general
evaluation of chemical methods for the estimation of
adrenaline in blood, in an endeavour to find a suitable
technique which could be established and employed for
basic and clinical research on the mode of action of
drugs used in general anaesthesia.
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A CONSIDERATION OF CHEMICAL METHODS FOR THE
ESTIMATION OF ADRENALINE
In 1356, Vulpian described the formation of a green
colour when the adrenal medulla was moistened with ferric
chloride; iodine produced a red coloration. The medulla
was shown to develop a blue colour with ferric sulphate
(Colin, 1356), while the formation of a brown colour on
adding dichroraate to adrenal extracts was described by
Henle in 1365. These observations laid the foundation
for subsequent attempts to estimate adrenaline by chemical
means•
Following the isolation of the physiologically
active principle of the adrenal medulla, by Takamine and
by Aldrlch (1901), attempts were made to utilise
various colour reactions for the estimation of adrena¬
line in medullary extracts:
(1) Iodine reaction (rose-red) suggested by
Abelous, Soulie and Toujan (1905).
(2) Fr&nkel-Albers reaction, employing potassium
bi-iodate and phosphoric acid (1909). The
same reddish-violet colour was produced by
the action of iodic acid (Krauss, 1903).
(3) Comessatti?s reaction (red) using mercuric
chloride (1909).
(4) Potassium persulphate reaction (Ewins, 1910).
Ewins (1910), in an appraisal of the above methods,
pointed out that the colour reactions were wholly or in
part dependent on the oxidation of adrenaline. This was
also the basis of the methods employing manganese dioxide
(Zanfrognini, 1909), gold chloride (Gautier, 1912), and
potassium ferricyanide (Cevidalli, 1909); indeed, it soon
became obvious that adrenaline could be oxidised by most
of the common oxidising agents, the red oxidation product
then being estimated colorimetrically. The typical
"chromaffin" staining reaction (Henle, 1&65), with
dichromate, has more recently been shown to be due to the
direct oxidation of adrenaline or other related aromatic
phenol derivatives (Bennett, 1941). Furthermore, the
reaction does not require dichromate - various oxidising
saltswill produce a similar colour (Gerard et al. 1930).
In a comprehensive review of the colorimetric tests
for the estimation of adrenaline Barker, Eastland and
Evers (1932) classified the methods described in the
literature into three groups:
(1) Those dependent primarily on the formation of
a red coloured oxidation product:
Ferric chloride reaction




Reaction with other oxidising agents -
hydrogen peroxide, potassium ferri-
cyanide, potassium permanganate,
potassium dichromate, sodium bismuthate,
sodium hvpobromite, manganese dioxide,
and the halogens.
3.
(2) Those dependent on the presence of the
catechol grouping:
Folin's reagent - phosphotungstic acid.
Ammonium molybdate reagent.
(3) A miscellaneous group:
Diazobenzenesulphonic acid reaction.
Azzolinifs test (1931).
Orru's test - ninhydrin (1929).
Reaction with ferrous sulphate and
sodium phosphate.
Miscellaneous group
The diazobenzene sulphonic acid reaction was des¬
cribed by Friend (1923) for quantitative estimation of
adrenaline in urine, and it was used by Sansoni (1930),
who considered it sensitive and easy to apply. Barker
et al., however, found no definite red coloration either
with pure adrenaline or with urine to which adrenaline
had been added. The tests described by Azzolini (1931),
Orru (1929), and Paget (1931) were found to be so
unspecific that they were unreliable even in qualitative
tests. The ferrous sulphate-sodium phosphate reaction
was too insensitive.
Ferric chloride reaction
This is characterized by the formation of a
transient grass-green coloration, changing to red on
standing, by careful addition of alkali or, most rapidly,
by boiling. However, Barker et al. (1932) stated that
ferric chloride solution alone gave a similar colour on
boiling. Also, adrenal cortical extracts which contained
no adrenaline gave duplicate reactions with this test.
Potassium iodate reaction
This was applied quantitatively by Hale and Seidell
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(1911), who correlated the results obtained using iodate
with those obtained by biological assay (pressor
response). They found the activity as determined by
chemical assay to be 30 per cent lower. In spite of this,
they considered the test suitable for assay of adrenal
extracts. The iodate reaction was also studied by
Scoville (1920). An orange-red colour was produced in
neutral solution, and a reddish-violet colour in the
presence of acetic or hydrochloric acid. According to
Barker et al. (1932), the method compared favourably with
the biological methods provided the acidity of the original
solution was known and reducing substances such as
bisulphite were absent. Concentrations above 1/100,000
could be estimated, and it was comparable to the per¬
sulphate test which, however, was easier to perform.
Potassium persulphate reaction
Ewins (1910), had described this test as the most
sensitive for adrenaline, claiming a sensitivity of
1/5,000,000, but Barker et (1932), found the lower
limit to be 1/100,000, and they investigated the test in
detail, finding it to be the most specific for adrenaline
of all the tests they examined. It appeared to depend on
the presence of a substance containing a benzene ring with
an OH group in the para-position on the ring and a primary
or secondary amino-group on the side-chainThus, Ewins
(1910) found the following bases allied to adrenaline would
give a positive persulphate reaction - epinine; noradrena¬
line; dihydroxyphenylethylamine (2). Oxidation products
such as amino-aceto catechol (3) and its derivatives did
not give the reaction. Although not as sensitive as Folin's
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teat, the persulphate reaction was considered by Barker
et al.. to be sufficiently accurate to be used for the
determination of adrenaline in adrenal glands and for other
similar purposes.
Mercuric chloride reaction
This was originally suggested by Comessatti (1909)
and modified by Ewins (1910). Its application to adrenal
gland extracts was reported by Bailly (1924), and by Paget
and Loheac (192&). It was further modified by Stuber,
Russmann and Proebsting (1923a) who claimed a sensitivity
of 1/100,000,000, by adding to adrenaline solutions a
mixture of sulphanilic acid, potassium iodate and mercuric
chloride, then boiling. However, Barker et al., did not
find this test to be sufficiently sensitive. They also
found that the reagents themselves produced an orange
brown colour on boiling.
Amonium molybdate reaction
This te3t was described by Rae (1930), and depends
on the catechol grouping in the adrenaline molecule, a
yellow colour being produced. Although not as sensitive
as the persulphate reaction, the test could be used for pure
solutions down to a concentration of about 1/20,000. It
was found by Barker _et al., to give misleading results for
adrenal gland extracts, and it could not be applied to
urine because of the presence of other phenolic substances.
Phosphotungstic acid reaction
Folin's reagent was described for the determination
of uric acid (Folin and Denis, 1913), but its sensiti¬
vity for adrenaline was found to be three times that for
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uric acid. However, ascorbic acid, glutathione, and most
easily oxidisable substances gave some blue colour,
especially the aromatic polyhydroxy-compounds (4). The
test was applied to adrenaline by Folin et al. (1913),
by Maiweg (1922) and by Barker and Marrian (1927), but
Barker et al,, found that the method gave too high results
when applied to adrenal extracts. They modified the test
by using sodium hydroxide in place of sodium carbonate, the
increased alkalinity enhancing its reliability; with pure
solutions a straight line was obtained for the colour
concentration curve.
The conclusions drawn by Barker et; al. (1932), from
their study of the available colorimetric test.s for adrena¬
line, were as follows:
The potassium persulphate test, although not
as sensitive as the phosphotungstic acid test of
Folin, gave results comparable with those
observed by biological assay when the necessary
conditions, including control of temperature and
pH were observed (5). The potassium iodate
reaction also appeared satisfactory but was less
extensively studied. The ferric chloride, ammonium
molybdate and phosphotungstic acid tests were non¬
specific. The latter test was extremely sensitive
however and gave good results with comparatively
pure adrenaline solutions. The other tests were
unsatisfactory even from a qualitative point of view.
7.
Colorimetric estimation of adrenaline In blood
Battelli (1902a) appears to have been the first to
attempt an estimate of the adrenaline content of blood by
means of a chemical method. He used the ferric chloride
reagent, which was both insensitive and unspecific since
bilirubin and other substances present in blood give the
same colour as adrenaline; the reaction is also influenced
by pH (Pekkarinen, 194$). Wiesel and Schur (1907) also
used the ferric chloride test.
In 1913, Folin, Cannon and Denis used their phospho-
tungstic acid method for blood adrenaline estimations, and
they affirmed: "It is worthy of note that incidental
experiments have proved that the method here described is
sufficiently delicate, when applied to blood taken from
the adrenal veins, to give a stronger colour reaction
after stimulation of the splanchnic nerves than before."
The same method was also used by Autenrieth and Quantmeyer
(1921).
However, Johannessohn (1916) considered that both
oxidising and reducing methods for the chemical estimation
of adrenaline were only suitable for pure solutions.
The problem of estimating adrenaline in blood was
one of considerable difficulty, because of the presence of
interfering substances which were capable of producing false
positive results in the available colorimetric tests.
Ascorbic acid, glutathione, various polyhydroxy compounds,
ergothione, uric acid and indeed many reducing substances
were possible contaminants (6).
s.
In 1923, an important step toward the effective
separation of adrenaline from biological extracts prior
to colorimetric estimation, was taken by Whitehorn, who
described the use of "permutit" for this purpose. Two
years previously, Whitehorn had observed that adrenaline
could be completely removed from solution by gentle
shaking with "permutit," "Permutit," the trade name
for a synthetic zeolite (or alumino-silicate) of the
approximate composition 2 SiC>2, AI2O3, Na20.6 H2O, is
used industrially for softening water and refining sugar.
Whitehorn found that all the substances removed by
"permutit" were relatively strong bases (with a basic
dissociation constant of 5 x 10"^ or greater (7) ) and
it could be used to separate relatively strong nitrogen
bases from weaker nitrogen bases or non-basic substances.
"Permutit" removed alkalylamines (£); the strongly basic
amino-acids, e.g. lysine, arginine and histidine were
also removed. The reaction was reversible, occurring
by a process of "trading bases" and obeying the "Law of
Mass Action" (9). According to Whitehorn, the following
substances were not taken up by "permutit" - urea, uric
acid, the amino-acids creatine, creatinine, non-basic
polyphenol compounds (10). The ability of "permutit" to
remove bases from solution was found to be adversely
affected at low pH levels.
Although Whitehorn used "permutit" for separation
of adrenaline from blood, subsequently employing phospho-
tungstate reagent for colorimetric estimation, he was
justifiably sceptical about the values obtained - 1.5 mgm.
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adrenaline per litre in human blood.
In 1935i Whitehorn developed an improved chemical
method for the estimation of adrenaline in blood. This
was based on two principles:
(1) The use of a column of silicic acid,
through which the deproteinised blood filtrate
was passed, for the separation of adrenaline from
other reducing substances prior to colorimetric
estimation. This also served to concentrate the
adrenaline - 40 per cent of the adrenaline present
in 50 ml. blood filtrate was concentrated into
5 ml. (This required the use of a correction
factor). The adsorbed adrenaline was eluted from
the silicic acid column by means of sulphuric
acid.
(2) Utilisation of a sensitive arsenomolybdic
acid reagent for the determination, the reagent
being reduced by adrenaline to give a blue colour.
Whitehorn noted that the arsenomolybdic acid re¬
agent was not specific for adrenaline. The trioses,
glyceraldehyde and dihydroxyacetone, and the diose
glycolaldehyde, gave a strong reaction under the acid
conditions specified (11). There was no reduction with
hexoses or pentoses (12). Reduced glutathione, in the
concentrations found in blood, gave a marked blue colour.
However, this and non-basic reducing substances, and even
the strongly basic alkaloid ergothioneine, were allegedly
excluded by the use of silicic acid for adsorption of
adrenaline (13). Organic substances reducing the arseno¬
molybdic reagent could be grouped into thiols and
enediols (14). Monophenols, resorcinol, and uric acid
did not reduce the reagent (15).
Whitehorn stated "that the procedure devised to
insure specificity for adrenaline does accomplish that
purpose is perhaps best indicated by my uniform failure
to find by this method demonstrable quantities of
adrenaline in human venous blood." Serious errors
resulted, however, if the blood was not treated with
trichloroacetic acid within one minute of venipuncture.
This was later confirmed by Shaw (193$). If the blood was
allowed to stand for 10 to 15 minutes, the apparent
adrenaline rose as high as 120 jug, per litre. Whitehorn
also noted that small quantities of adrenaline added to
blood could be determined with lower losses than when
simply diluted with distilled water. In recovery experi¬
ments, Whitehorn recovered $4 to 107 per cent of added
adrenaline. The limit of sensitivity was 1/50,000,000.
The method of Whitehorn was employed by Dopy and
Weisinger (193$), but it was adversely criticised by
Eichler and Noack (1939) on the grounds that adsorption
of adrenaline on silicic acid was inefficient. However,
Kobro (1946), using a slightly modified version of
Whitehorn's method (1935), found average values of
40 to 50 jig. adrenaline per litre in peripheral venous
blood. Giordano and Zeglio (193$, 1939) also modified
the method of Whitehorn by taking blood (or other solu¬
tion containing adrenaline) into sodium thiosulphate to
prevent oxidation; however,they found excessively high
values of adrenaline in blood.
Barker et al. (1932), during their review of the
colorimetric methods for the estimation of adrenaline,
stated briefly that they found no adrenaline in the
filtrate obtained from the trichloroacetic acid preci¬
pitation of defibrinated blood, using the persulphate
test for estimation. Viale (1933), using a modified
mercuric chloride reagent, estimated the normal adrena¬
line content of dog blood to be about 2.5 rag. per litre.
Kobayashi (1935), using phosphotungstate reagent,
obtained values of about 70 jig, adrenaline per litre in
rabbit blood. Until 193$, when Shaw described his modi¬
fication of the method of Whitehorn, the chemical methods
for the estimation of adrenaline in blood appear to have
been quite unspecific.
Shaw demonstrated in 193$ that preliminary treat¬
ment of adrenaline with alkali, in the presence of
oxygen, increased the colour formed with arsenomolybdic
acid reagent. He stated: "adrenaline is known to be
oxidised under these conditions, and apparently one of
the products of oxidation is a more active reducing
agent than adrenaline itself; this product is itself
destroyed by longer exposure to alkali. The nature of
this substance is unknown." A series of substances
allied to adrenaline were tested, but none produced as
much colour as adrenaline (page 96). p-Sympatol was the
only substance which resembled adrenaline in showing an
increased colour after treatment with alkali.
Shaw concluded that if the reducing power of a
tissue extract was increased by treatment with alkali
the observation could be taken as evidence that the
extract contained adrenaline or some other phenol with
a similar side chain. As Whitehorn had stated earlier,
a number of substances other than phenols reduced the
arsenomolybdic acid reagent; in the list of interfering
substances Shaw included (the enediol) ascorbic acid
and the alkaloid eserine (which contains a benzene ring)
but he stated that these interfering substances were not
adsorbed by the aluminium hydroxide used for the separa¬
tion of catechol amines (16).
Shaw utilised specially prepared aluminium
hydroxide for the adsorption of adrenaline. To avoid
the use of a correction factor, the aluminium hydroxide
was afterwards dissolved in the reagents of the test,
so that it was hoped to recover adrenaline completely.
The optimum pH for adsorption was found to be $ to S.5.
On the acid side of pH 6 there appeared to be no adsorp¬
tion of adrenaline. The deproteinised blood extract was
first shaken with aluminium hydroxide at pH 4 to remove
glutathione and other possible interfering substances.
According to Shaw, ascorbic acid was not adsorbed at
either acid or alkaline pH. After shaking with aluminium
hydroxide at pH 4, the supernatant was retreated with
aluminium hydroxide at pH S.5. The aluminium hydroxide
was then dissolved in alkali, heated, and the solution
was treated with arsenomolybdic acid reagent. The esti¬
mations were carried out using a Leitz two-stage colori¬
meter. A blank and a standard solution were also run
through the method. For each estimation, the colour
produced by the unknown solution was compared with that
due to the adrenaline standard solution, the blank value
being subtracted from each.
Addition of adrenaline to rabbit's blood, 1 jig. per
ml., gave recoveries of 75 to BO per cent of added adrena¬
line. Shaw found good agreement between his colorimetric
method and biological assay (pressor effect) of adrenal
extracts. Although the method could estimate 0.04 yug.,
it was preferable that the unknown solution should con¬
tain at least 0,1 to 0.5 J*g* The limit of sensitivity
for tissue extracts was 10"^. (In human blood, Shaw
found 16 to 20 jag. adrenaline per litre).
The method of Shaw was employed by Sarfy (1933,
1939) and by Tietz, Dornheggen and Goldman (1940).
Bloor and Bullen (1941) encountered several difficulties
with the technique. Variability in the value of the blank
solution had been experienced by Whitehom (1935) and by
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Shaw (193&), and Bloor and Bullen automatically corrected
for the blank solution by using it as the reference in
the photoelectric colorimeter. In the preliminary acid
adsorption, one drop of sulphuric acid, added to the blood
filtrate as suggested by Shaw, was found to be insuffi¬
cient to prevent adsorption of adrenaline on aluminium
hydroxide. More acid was required, which had the effect
of dissolving a large part of the aluminium hydroxide.
Again, in the addition of alkali suggested by Shaw to
increase sensitivity, the aluminium hydroxide did not
dissolve completely, and the increase in colour was small
and uncertain. Bloor and Bullen therefore modified the
procedure by omitting the preliminary acid adsorption
and the pretreatment with alkali.
During their early work with the method, colours
corresponding to values of 0.2 to 0.5 jug/ml. adrenaline
were found in the venous blood of dogs and humans. They
utilised the instability of adrenaline in alkaline solu¬
tion to determine whether adrenaline was in fact respons¬
ible for the blue coloration produced by a given sample.
This required two estimations, with and without alkali,
the amount of adrenaline present being shown by the
difference between the two values (corrected for the
10 per cent by which the values for reducing substances
present in blood were elevated by the alkali treatment).
The colour produced by venous blood was stable to alkali
under conditions in which adrenaline added to blood was
completely destroyed. Blood extracts, to which adrena-
linehad been added, when treated with alkali, gave the
same or slightly higher values than extracts containing
no adrenaline. This cast serious doubts on the exis¬
tence of any adrenaline in venous blood - the limit of
sensitivity of the method used by Bloor and Bullen was
0.001 jug. per ml. and they claimed an accuracy of 5 per
cent in recovering 0.015 to 0.25 yug. adrenaline.
Raab (1941) considered Shaw's method to be non¬
specific, and initially believed that the colour corres¬
ponding to adrenaline in the blood was produced by
adrenaline-steroid complexes. This conception was later
abandoned, but Raab (1943) showed that the method of Shaw
estimated adrenaline-like substances containing a catechol
nucleus, and ascorbic acid, which Raab found to be quanti¬
tatively adsorbed on aluminium hydroxide at pH 3.5.
Shaw's method was employed by West (1947) in a modi¬
fied form using blood dialysate in the course of a com¬
parison of colorimetric, fluorimetric, and biological
tests for adrenaline in rabbit's blood. Although
recovery of added adrenaline was satisfactory, "normal"
values for the adrenaline content of rabbit blood, 120
pg. per litre, were excessively high. Furthermore, the use
of aluminium hydroxide during the blood dialysis (Jorgensen,
1945) suggests that a proportion of the adrenaline present
would be removed by adsorption, indicating that the colour
estimated as adrenaline was in fact largely produced by
spurious factors.
Methylene blue was employed by several workers for
the estimation of adrenaline in tissue extracts (Thunberg,
1913; Ahlgren, 1921; Euler and Liljestrand, 1929); the
method depends on the rate of decay of the blue colour
under the Influence of adrenaline. Using this method,
von Euler (1933) reported a figure of 0.0001 pg. adrenaline
per 100 ml. in human blood. The results were said to be
affected by blood glucose (Konschegg and Monauni, 1933),
and the method did not gain wide acceptance.
Before considering the fluorimetric techniques of
adrenaline estimation, mention should be made of the iodine
method of Euler and Hamberg (1949). This depends on the
different rates of oxidation of adrenaline and noradrenaline
with iodine, at pH 4 and pH 6J the colour produced by
adrenochrome and noradrenochrorae (and their iodo-deriva-
tives), at 1| and 3 minutes after the addition of iodine,
allowed the differential estimation of a mixture of the
two amines. Although suitable for the estimation of
adrenal and other tissue extracts when purified by adsorp¬
tion of amines on alumina, the sensitivity of the method
does not allow the determination of adrenaline in amounts
below 10 yug. (Suler and Floding, 1955).
Fluorimetric chemical estimation of adrenaline in blood
Loew (191$) was the first to observe a yellowish
green fluorescence when strong alkali was added to solu¬
tions of adrenaline. Paget (1930), during the color!-
metric estimation of adrenaline with amonium molybdate
reagent, observed that the reddish-brown colour dis¬
appeared and was replaced by a green fluorescence when
sodium carbonate was added. The green fluorescence
allowed the estimation of adrenaline 1/2,000,000. Barker
et al. (1932) noted that addition of alkali to adrenaline
solutions which had been treated with ferric chloride
produced a yellow fluorescence similar to that produced
in the ammonium molybdate test. This reaction appeared
to be a very sensitive and reliable qualitative test for
adrenaline.
In 1934, Gaddum and Schild described a test for
adrenaline in pure solution, the essential reagents being
adrenaline, oxygen, and alkali (in this case 5 N, sodium
hydroxide (17) ). A definite green colour was produced
a
by adrenaline 10" . Several substances chemically related
to adrenaline were tested, and the fluorescence produced
twenty seconds after adding alkali was estimated as a
percentage of that produced by adrenaline. The findings
were:
"dopa" 3 per* cent;
noradrenaline 2 per cent;
epinine 2 per cent;
catechol 0.1 per cent;
tyramine and ephedrine, nil.
In sensitivity this test represented a definite
advance over the earlier chemical methods for the estima¬
tion of adrenaline. However, attempts to use the method
for blood were unsuccessful. Gaddum and Schild found that
the fluorescence due to low concentrations of added adrena¬
line was obscured by blue fluorescence due to proteins and
other substances which could not be removed; also, and of
considerable importance, it was found that deproteinisation
by means of trichloroacetic or metaphosphoric acid removed
added adrenaline. This observation was later confirmed by
D'Silva (1937), who found that no more than 61 per cent of
adrenaline added to plasma (0.1 jig. per ml.) was recovered
when the plasma was aeproteinised with trichloroacetic acid.
Also, during ultrafiltration of plasma containing adrenaline
(0.05 to 0.2 mgra. per ml.) there was a 17 per cent loss of
adrenaline, due either to oxidation, or more probably to
the combination of adrenaline with plasma proteins. The
effects of deproteinisation were later emphasised by
Lehmann ana Michaelis (1942a) who found losses of 50 per
cent of added adrenaline; von Porat (1946) who reported the
loss to be considerable; and. Lund (1949c) who found that
removal of proteins involved a loss of 60 to 70 per cent
of added adrenaline.
The fluorescence reaction described by Gaddum and
Schild (1934), although used without success for blood,
plasma, and serum by Tieg (1934) and by Konzett and Weiss
(1939), became the basis for later methods of estimation
of adrenaline in blood (Hueber, 1940; Kalaja
and Savolainen, 1941; Lehmann and Michaelis, 1942b}.
The problem of separation of non-specific interfering
substances from blood presented even greater difficulties
with the fluorescent techniques than with the colorimetric
methods because of the greatly increased sensitivity
obtainable. Von Hueber (1940) suggested the use of
dialysis as a means of separating adrenaline from blood
(13). This was adopted and modified by Kalaja and
Savolainen (1941), who used haemolysed blood, with a
buffer solution (19) of pH 4 as receiving fluid to which
aluminium hydroxide was added to remove adventitious
fluorescing substances from the dialysate. Jorgensen
(1945) employed a similar method, but used sodium citrate
as an anticoagulant, which may have adversely affected
the results because of displacement of pH to about 7, at
which adrenaline would be largely adsorbed by the
aluminium hydroxide. However, Jorgensen found an average
level of 63 yug, adrenaline per litre in peripheral venous
blood.
Pekkarinen (1943), using dialysis and omitting
dilution of the blood with 0.01N HC1 (previously used
for stabilisation of adrenaline), displaced the pH of
the dialysate to about pH 3.5, at which adrenaline was
largely adsorbed. The precipitate was then dissolved
in sodium hydroxide and the fluorescence of the solu¬
tion measured. Pekkarinen found no adsorption of inter¬
fering substances which, it should be remembered, was the
original object of using aluminium hydroxide in the
dialysis method. The sensitivity of the method as used
by Pekkarinen was 5 to 10 jig. per litre; no adrenaline was
found in peripheral blood under normal conditions, although
he estimated a value of 10 to 100 jig. per litre in the
adrenal vein of dogs under ether anaesthesia.
Von Porat (1946) found the dialysis method to be
unserviceable because of an inhibitory effect on adrenaline
fluorescence produced by the blood dialysate; it was later
shown (Bloch, 194$) that addition of a blood dialysate to
an aqueous solution of adrenaline was able to almost totally
inhibit the development of fluorescence on addition of
strong alkali. Also, von Porat found that the dialysis
method gave high blank values and uncertain quantitative
recovery.
Lehmann and Michaelis (1942a) had earlier criticised
the dialysis method on the ground that there was a loss of
adrenaline in the process of dialysis; that there was no
control over oxygen tension during dialysis; and that the
presence of heavy metal ions, especially iron, inhibited
the development of fluorescence - this was investigated by
Jorgensen (1945), who found no interfering effect from
heavy metal ions present in normal blood dialysates,
Lehmann and Michaelis (1942b) employed small quanti¬
ties of plasma, and after addition of alkali the fluores¬
cence was estimated in a photofluorimeter; they attempted
to eliminate the blue fluorescence produced by proteins by
means of suitable interference filters.
Von Porat (1946) modified the method of Lehmann and
Michaelis by achieving protein precipitation with
tungstic acid, which strongly activated the adrenaline
fluorescence. By this means, it was possible to demons¬
trate 0.25 pg. adrenaline per ml. in recovery experiments,
but no adrenaline could be demonstrated in plasma.
West (1947) using a dialysis method followed by
fluorimetric estimation (based on the method of Jorgensen,
1945) estimated the average adrenaline content of rabbit
blood to be 100 jig. per litre.
Annersten £t al. (1949) pointed out that the use of
blood plasma (Lehmann and Michaelis, 1942b) had given
notably higher adrenaline values than the blood dialysate
method (von Hueber, 1940; Kalaja and Savolainen, 1941;
Jorgensen, 1945; West, 1947). Annersten et al., carried
out separate determinations on blood and plasma dialysates
and imperraeates, and on plasma. While direct estimation
on blood plasma, and on the plasma impermeate, yielded
figures of 1 to 3 |ig. adrenaline per ml., 0.07 jig. per ml.
was found in the dialysates, showing that only a small
percentage of the adrenaline had passed through the collo¬
dion membrane. Their conclusion was that the two modifica¬
tions of the fluorescent method yielded incompatible results.
On the one hand, free dialysable adrenaline was determined,
whereas on the other, total adrenaline content including
free and protein-bound adrenaline. However, in view of the
excessively high values found in plasma and in plasma
dialysates by Annersten et al., their conclusions must be
seriously in doubt.
It must be admitted that the early fluorimetric methods
for the estimation of adrenaline in blood were a
considerable advance over colorimetric techniques both
in sensitivity and specificity. However, there were
many problems remaining. One of these was the unsuita-
bility of the dialysis method for the extraction of
adrenaline from blood, because of poor recovery of
adrenaline, an inhibiting effect on adrenaline fluores¬
cence, and the inadequate separation of interfering
substances. Disputes on the suitability of the dialysis
method were also due in part to the lack of knowledge of
the influence of acidity on the adsorption of adrenaline
by aluminium hydroxide.
The use of whole plasma was certainly no more
satisfactory, because of the introduction of adventitious
fluorescence, which was not overcome by the use of inter¬
ference filters during measurement. The fluorescence of
the sample was compared with eosin standard solutions
(Kalaja and Savolainen, 1941; Pekkarinen, 194$), or it
was measured by Pulfrich's photometer (Lehmann and
Michaelis, 1942b). Von Porat (1946) used a glass fluores¬
cence standard. The extremely weak fluorescence shown
by the small quantities of adrenaline present in blood
dialysates, and the spurious fluorescence introduced by
contaminating substances which were incompletely separa¬
ted from the solutions whose fluorescence was being
measured, must have made for great inaccuracy with these
available methods of measurement. Also, when standard
fluorescent solutions were used for comparison with the
sample, they were calibrated against pure solutions of
adrenaline. This left out of account the possibility
that the fluorescence due to adrenaline was inhibited
by substances present in blood dialysates.
An attempt has been made to bring to the fore the
salient features of the earlier chemical methods utilised
for the estimation of adrenaline in blood, prior to the
recent techniques of Lund (1950), and Weil-Malherbe and
Bone (1952a). A table adapted from Pekkarinen (194&),
which summarises the results obtained with all the
reported methods prior to 1949, is provided on pages 9$ - 100.
The Oxidation of Adrenaline
Following the observations by Vulpian in 1&56, and
in the course of the early attempts to estimate adrena¬
line by agents such as ferric chloride, potassium iodate,
mercuric chloride, and potassium persulphate, it became
appreciated that the colour reactions were brought about
by the oxidation of adrenaline, usually to a red coloured
oxidation product. The chemical nature of the oxidation
product was for many years unknown. In 1933, Ball and
Chen measured the oxidation products of the systems
formed by treating adrenaline with oxidising agents, and
obtained evidence that the primary product formed was
generally the corresponding ortho-quinone (page 102).
This was extremely unstable, and at pH 7 was found to
change within l/30 second, Irreversibly, to give a
product of undetermined chemical structure. In 1937,
Green and Richter isolated this compound, which contained
four hydrogen atoms less than adrenaline, and it was
shown to have the properties of N~methyl-2:3-dihydro~3-
hydroxyindole-5:6 quinone. This substance is a conden¬
sation product between carbon atom 2 in the benzene
nucleus of adrenaline and the amino-group under the ring
formation. It was named "adrenochrome" by Green and
Richter.
Adrenochrome was found to be very unstable, and in
solution even under the optimum conditions of storage, at
pH 4 and a temperature of 0°C, there was considerable de¬
composition and melanin formation in four to five hours (20).
The Production of Fluorescence
It was shown by Gaddum and Schild (1934) that oxygen
was reouired for the production of fluorescence when
alkali was added to a solution of adrenaline. Shaw (1941)
ascribed the fluorescence to adrenaline ouinone, while
Rangier (1945) suggested the isomeric leuco-adrenaline (21)
Ehrlen (194&) was the first to identify the fluorescent
compound as l-methyl-3:5:6:-trihydroxyindole (pagel02).
This was independently verified by Fischer (1949), by Lund
(1949b), and by BuLock and Harley-Mason (1951).
Lund (1949a) showed that addition of alkali to
oxygen-free solutions of adrenochrome produced a strong
fluorescence almost at once, the fluorescence being reduced
by addition of oxygen; thus the fluorescent substance was
at the same degree of oxidation from adrenaline as was
adrenochrome. Oxidation of adrenaline in acid solution
gave the red non-fluorescent adrenochrome, while oxidation
in alkaline solution formed the yellowish-green fluores¬
cent substance. Lund (1949b) prepared the fluorescent
compound in crystalline form, by rearrangement of adreno¬
chrome in oxygen-free solution in the presence of a strong
base, subsequently precipitating the fluorescent substance
with acid. He named it "adrenolutine" and suggested the
sequence of events shown on page 102 for the oxidative break
down of adrenaline.
Following his identification of adrenolutine, Lund
(1949c) introduced his method for the estimation of adrena¬
line in blood. Although in many respects new, Lund's
method was dependent on the production of fluorescence
with alkali, as previously described by Gaddum and Schild
(1934). As in every method for the chemical estimation
of adrenaline in blood, two distinct problems were invol¬
ved - the separation of adrenaline from blood, and the
estimation of the separated adrenaline.
(1) The isolation of adrenaline from blood
In face of the confusion arising from the use of
aluminium hydroxide for adsorption of adrenaline and
other substances at different pH values, Lund investigated
the effect of pH on the adsorption of adrenaline by alum¬
inium hydroxide and aluminium oxide. With aluminium
hydroxide no adsorption of adrenaline occurred between pH
4 and 5. With rising pH values, increasing amounts of
adrenaline were adsorbed, but at pH 3 to 9 adsorption was
still incomplete. With aluminium oxide (AlgO-j for chroma¬
tography, B.D.H.) adsorption and acidity were similarly
interrelated, but 94 per cent adsorption occurred at pH
3.4 (pags 101). By using aluminium oxide contained in a
glass column through which the samples were drawn by
suction, 92 per cent of adrenaline was recovered from pure
solution. Loss of adrenaline on the column was considered
to be probably due to oxidation in the alkaline solution
during filtration. This implied that the necessity to
keep the alkalinity sufficiently low to prevent oxidation
of adrenaline conflicted with the need to keep the pH of
the adrenaline solution at about 3.4» where adsorption of
adrenaline was at a maximum.
From plasma samples, SO per cent recovery of
added adrenaline (20-200 jxg. per litre) was consistently
obtained, Lund attributed the 20 per cent loss with
plasma filtrates to washing of the column with sodium
acetate.
2, The estimation of adrenaline
Lundfs method was based on the quantitative
oxidation of adrenaline to adrenochrome, this reaction
being complete after a plasma eluate was shaken with
manganese dioxide for 30 seconds; the adrenochrome was
then further oxidised with 20 per cent sodium hydroxide
to the fluorescent compound adrenolutine. When alkali
had been added, further oxidation of adrenolutine was
prevented by means of ascorbic acid (Ehrlen, 1943), the
affinity of sodium ascorbate for oxygen being consider¬
ably greater than that of adrenolutine,
Lund affinned that the use of manganese dioxide
resulted in a considerable increase in sensitivity; the
maximum fluorescence after addition of alkali to adrena-
aline solutions was only one-fourth to one-third of
that measured when the adrenaline solution had been
previously oxidised with manganese dioxide.
In 1950, Lund modified his original procedure to
allow the simultaneous estimation of adrenaline and
noradrenaline in the same sample. Noradrenaline was
found to behave like adrenaline with regard to adsorp¬
tion on aluminium oxide, quantitative adsorption occurring
at pH $.5. The oxidative process, noradrenaline
noradrenochrome- > noradrenolutine was analogous to that
for adrenaline. However, it was found that while adrena¬
line was quantitatively oxidised to adrenochrome within
the pH range 3 to 7, only 5 per cent of noradrenaline
was oxidised to noradrenochrome at pH 3, although quanti¬
tative oxidation occurred at pH 6.5. This was utilised
for the differential estimation of adrenaline and nor¬
adrenaline in blood. Because of the importance of Lund's
technique and its excellent specificity, the technique
of estimation will be briefly described.
After chromatographic adsorption of plasma adrena¬
line and noradrenaline on a column of aluminium oxide
(this is detailed in the subsequent description of the
ethylene diamine condensation method employed by the
author), elution is carried out with 10 ml. 0.2N acetic
acid and 10 ml. water. The eluate is divided into three
portions, each of 10 ml. A, B, C.
(A) This is the blank solution; with it, by
potentiometric titration, is estimated the required amount
of O.&M sodium acetate or 0.2N hydrochloric acid to bring
solutions of C and B to pH 6.5 and 3.0 respectively. A
is then shaken for 20 seconds with 0.1 gm. manganese
dioxide (previously washed with acetic acid and water to
get rid of fluorescent substances) at pH 6.5, centrifuged
for 30 seconds at 3000 rpm and filtered {the filter
paper having been washed free of fluorescent substances).
To 3 ml. of the filtrate is added 0.34 ml. of 20 per
cent sodium hydroxide. Oxidation of adrenaline to
adrenochrome and rearrangement to adrenolutine then
occurs, followed by complete oxidation of adrenolutine
within 2 to 3 minutes. Five minutes after adding the
alkali, 0.16 ml. of 1 per cent ascorbic acid is added
to the faded blank solution.
(B) Is used for the determination of adrenaline.
The previously determined amount of 0.2N hydrochloric
acid is added to bring the pH to 3.0. The solution is
then oxidised for 60 seconds with manganese dioxide.
After centrifuging and filtering, 1 ml. of a mixture of
1 ml. 20 per cent sodium hydroxide and 0.20 ml. of 1 per
cent ascorbic acid is added to 3 ml. of the filtrate.
As in solution A, the adrenaline is oxidised to adreno-
chrome and rearranged to adrenolutine, but further oxida¬
tion is prevented by the ascorbic acid.
(C) Is used for determination of adrenaline plus
noradrenaline. The previously determined amount of 0.3M
sodium phosphate is added to the sample, bringing the pH
to 6.5. The solution is oxidised for 20 seconds with
manganese dioxide. After centrifuging and filtering,
1 ml, of the sodium hydroxide-ascorbic acid mixture is
added to 3 ml. of the filtrate.
The fluorescence of solutions B and C could be
measured immediately after the addition of sodium hydrox¬
ide-ascorbic acid, but it was necessary for the blank
solution to stand for about 30 minutes to allow its
fluorescence to fade completely. It was previously mention¬
ed that at pH 3.0 only about 5 per cent of the noradrena¬
line present was oxidised to noradrenochrome. Moreover,
the fluorescence shown by noradrenolutine was just over
half of that produced by adrenolutine, so that the floures-
cence due to noradrenaline in solution B was usually only
a small fraction of that due to adrenaline. Therefore,
to simplify the calculation of results, Lund ignored the
fluorescence derived from noradrenaline in solution B.
A sensitive photofluorimeter is necessary to record
the fluorescence intensity of the three solutions.
For calculation of results, Lund employed previously
determined calibration curves (galvanometer deflections
plotted against fluorescence intensity). The deflections
produced by solution A were subtracted from those given
by solution B, and from the adrenaline calibration curve
the adrenaline concentration was found. The deflections
produced by solution B were then subtracted from those
produced by solution C, and from the noradrenaline cali¬
bration curve the noradrenaline concentration in the eluate
was determined. Previous correction was made for dilution
of solutions 4 and B with hydrochloric acid and sodium
phosphate solutions, and the concentrations determined
were corrected by the factor 1.25» because of the constant
20 per cent loss of amines, thought to be due to washing
of the column with sodium acetate.
The adrenaline concentration in plasma could be
estimated with an accuracy of - 5 per cent with concen¬
trations above 10yug. per litre and - 10 per cent within
the range from 1 to 10 yug. per litre. For noradrenaline
the lower limit of sensitivity was 10yug. per litre, the
accuracy rarely exceeding 10 per cent if the concentra¬
tions of adrenaline and noradrenaline were of the same
order.
Specificity of the Fluorescence Reaction
Lund investigated several compounds chemically
related to adrenaline (page 103}.
Propynaline and noradrenaline proved to be the
only two of these compounds which on oxidation and
addition of alkali yielded the yellowish-green fluores¬
cence characteristic of adrenaline.
The requirements for this fluorescence reaction
are:
(1) Indole rinp; closure - determined by the presence
of a secondary amino group.
(2) Formation of the quinone - two adjacent OH
groups are required on the benzene ring.
(3) Autoreduction to give the fluorescent oxida¬
tion product requires, on the side chain, a hydroxyl group
at the 0 -carbon (next to the benzene ring), and hydrogen
at the oC -carbon (Lund, 1949c; Bu'Lock and Harley Mason,
1951).
As Lund stated, "the only two remaining possibili¬
ties for substitution are therefore at thecC and ft carbon
atoms of the side chain. Such substitution products are
unknown, either as drugs or as intermediary substances
normally present in the organism. Numerous other types
of compounds show yellowish-green fluorescences, e.g.
indoxyl derivatives (22), of which a few occur as meta¬
bolic waste products in the organism. However, indoxyl
propionic acid and2-carboxy-indoxyl-acetic acid proved
to be non-fluorescent as were related compounds such as
the amino-acids tyrosine and tryptophan."
Although not tested by Lund, isopropylnoradrenaline,
in accordance with its chemical structure, gives a strong
fluorescence with this method (Von Euler and Floding, 1955)
while small amounts of isopropylnoradrenaline have been
tentatively identified in adrenal extracts (Lockett, 1954),
their presence under normal physiological conditions is
not established. A very weak fluorescence is also produced
by dopamine and 3:4-dihydroxynorephedrine (Corbasil,
cobefrine) (Von Euler and Floding, 1955), (23).
Weil-Malherbe and Bone (1952a)criticised the method
of Lund for these reasons;
(1) Recovery of added adrenaline was only &0 per cent.
(2) The sensitivity for adrenaline was above 10 jig, per
litre of blood.
(3) It was necessary to remove manganese dioxide rapidly
and completely.
(4) The possibility existed that adrenochrome might be
reduced by ascorbic acid, thus escaping rearrange¬
ment to adrenolutine in alkaline solution.
(5) Variations in temperature, and in the manganese
dioxide employed, might interfere with the method.
Although inadequate sensitivity was an important
drawback to the application of Lund's method, this could
be improved by the use of a more sensitive photofluori-
meter (Weil-Malherbe and Bone,1952a; Valk, 1955; Ludemann
et al. 1955). By incorporating several modifications
into the method of Lund, including the use of a Farrand
photofluorimeter, Ludemann et al. (1955) increased repro¬
ducibility and sensitivity, allowing the estimation of
2 jug. adrenaline per litre of plasma. Oxidation of the
standard solutions at the same pH as the plasma eluates
(pH 3.5 to 4.1) apparently overcame the constant loss
of 20 per cent incurred by Lund (1949c); 102 per cent
recovery of added adrenaline (10 jug. per litre) was
achieved. However, sensitivity of the method remained
inadequate; control levels of adrenaline concentration
in 5 human subjects and 7 dogs were 0 to 4 ^ug. per litre
of peripheral arterial blood, while it was apparently not
possible to estimate levels between zero and 1 jug. per
litre, which appears to be the true normal range.
Furthermore, extremely high concentrations - 30 to 4&0
jug. adrenaline per litre - were estimated during severe
anoxia in dogs.
A further modification of Lund's method has
recently been described by Von Euler and Floding (1955).
Potassium ferricyanide (0.25 per cent) is employed in
preference to manganese dioxide for the oxidation of
adrenaline and noradrenaline, and zinc sulphate (0.5 per
cent) is added to increase the speed of formation of
adrenochrome at pH 3.5. In other respects, the method
is closely similar to the technique described by Lund
except for the use of a more sensitive fluorimeter
designed after the principles given by Weil-Malherbe and
Bone (1953). According to Von Euler and Floding, "the
method is rapid and easy to perform in any laboratory
having access to a suitable fluorimeter."
Although utilised by these workers for the chemical
assay of adrenaline in urinary extracts, the technique
appears to be adaptable to the estimation of plasma
concentrations of adrenaline and noradrenaline.
The method of estimation used in the studies to
be described in this thesis is essentially similar in
technique to that described by Weil-Malherbe and Bone
(1952a, 1953). The basis of the method is a condensation
reaction of catechol amines with ethylene diamine (24),(p.104),
originally described by Natelson et al. (1949). Natelson
pointed out that the fluorescence produced by the oxida¬
tion of adrenaline in alkaline solution, excited by a
wavelength of 365 mp, was not specific for adrenaline;
various substances such as protein hydrolysates, aged
tryptophan, and tyrosine, produced fluorescence under
similar conditions (25). Also, the fluorescence was
transient, a fact responsible for considerable diffi¬
culty in measurement, as previous workers had found.
Again, the fluorescent material was not completely
extractable with organic solvents, the fluorescence
being affected by salt concentration. Natelson found
that treatment of adrenaline solutions with an organic
primary amine such as ethylene diamine, butylamine,
propylenediamine, benzylamine, aniline or O-phenylene-
diamine, produced a fluorescence excitable by a wave¬
length of about 435 i^u, which did not excite the inter¬
fering substances listed above.
The fluorescent substance was found to be
extractable into aliphatic alcohols, e.g. butyl or amyl
alcohol. Fluorescence was quite stable and remained
constant for several days. The maximum emission of
fluorescent light occurred at about 570 mjx} there being
negligible emission below 500 n
This reaction was not further studied by Natelson
sLL« » but Weil-Malherbe and Bone (1952a) adopted it as
the basis of their method for the estimation of adrena¬
line in blood. They pointed out that oxygen was necessary
for the condensation reaction, and that if adrenaline
was replaced by adrenochrome a fluorescence intensity
curve was obtained, both in the presence and absence of
oxygen, which was identical to that produced by equimolar
amounts of adrenaline in the presence of oxygen.
In the method first described, the adrenergic
amines were collectively estimated as "adrenaline-like
substances." The fluorescence intensity produced by
noradrenaline was one fifth that produced by equimolar
amounts of adrenaline. The fluorescence produced by a
mixture of both substances was equal to the sum of the
fluorescences produced by the component parts. In a
subsequent paper, Weil-Malherbe and Bone (1953) modified
the method to allow the differential estimation of adrena¬
line and noradrenaline in plasma samples. The use of two
separate interference filters, and the increase in the
sensitivity of the fluorimeter, allowed advantage to be
taken of the maximum fluorescence emission of adrenaline
at about 5&0 mji, and for noradrenaline at about 450 mjx.
The initial separation of catechol amines from
plasma samples was accomplished, as in the method of
Lund (1949c),by adsorption on a column of aluminium oxide.
Weil-Malherbe and Bone cited these advantages for
the ethylene diamine method:
(1) The unstable, highly reactive adrenochrome
was trapped in the nascent state and forthwith converted
into a completely stable condensation product.
(2) The fluorescence remained constant for at least
24 hours.
(3) A sensitivity of 1 jig. per litre of blood could
be obtained.
(4) Recovery was quantitative; no correction factor
was needed,
(5) Additive results were obtained with adrenaline
and noradrenaline.
Specificity of the method
Weil-Malherbe and Bone found that fluorescence of
variable intensity was produced by all the catechol deri¬
vatives tested, with the exception of dihydroxyphenyl-
alanine. They alleged that this finding was of little
practical importance since physiological catechol deriva¬
tives such as dihydroxyphenylalanine were largely elimina¬
ted by the extraction procedure, (pages 105 - 106).
Direct extraction of plasma into isobutanol
(omitting the addition of ethylene diamine) showed that
fluorescence was less than that of the usual reagent
blank. This indicated that none of the fluorescence was
due to preformed plasm components, but was all produced
by condensation with ethylene diamine.
Other experiments performed by Weil-Malherbe and
Bone appeared to show that:
(1) Added adrenaline disappeared from plasma at
about the same rate as the preformed estimated adrenaline,
when auto-oxidised by shaking in air.
(2) Extract of rabbit liver removed preformed
material and added adrenaline from plasma at an equal rate
the liver extract was inactivated by boiling and inhibited
by ephedrine, a specific inhibitor of amine oxidase. It
was concluded that the liver extract owed its activity
to the presence of amine oxidase. This reaction was
further shown to be quantitative, the plot being that
of a first order reaction, indicating that the reacting
material was either a single substance cr a mixture of
substances with a similar affinity for the enzyme.
Paper chromatographic experiments were carried out
by Weil-Malherbe and Bone to obtain evidence of specifi¬
city. N-butanol was used to extract the plasma catechols
from 150 ml. blood. The extracted amines were then
re-extracted with 0.05N HC1 and the neutral concentrated
solution passed over a column of aluminium oxide. The
amines were eluted with acetic acid and the eluate evapora¬
ted. The residue was transferred to paper with acid
acetone and chromatographed by the method of Goldenberg et al.
(1949). Sections of the chromatogram were extracted with
dilute HC1 and the adrenergic amines in the extract were
estimated fluorimetrically.
The fluorigenic material in plasma was stated to
be concentrated in positions exactly opposite those of
the adrenaline and noradrenaline spots on a reference
strip. By employing the method developed for differential
estimation of the two amines (Weil-Malherbe and Bone,1953),
it was found that the substances with the same Rf value
as noradrenaline and adrenaline also yielded on condensa¬
tion with ethylene diamine a fluorescence with the same
spectral properties as that produced by condensation of
noradrenaline and adrenaline respectively (26).
Recovery
Both adrenaline and noradrenaline were stated to be
quantitatively recovered when pure solutions were estimma-
ted. Additions of adrenaline to horse serum, in amounts
equivalent to 2, 3, 5 and 10 yug. per litre, resulted in
a quantitative recovery with a standard deviation of 5 per
cent over this range. The values quoted for the differen¬
tial method were - adrenaline, 96.4 per cent - 5.44 per
cent, at levels of 2,3,4,5,1° and 15 yug. per litre;
noradrenaline, 100.7 per cent - 6.79 per cent, at levels
of 5,10,15 and 20 yug. per litre. This evidence of
quantitative recovery of added amines up to 100 per cent
is in disagreement with the &0 per cent recovery quoted
by Lund (1949c).
Adrenaline, 1 to 1.5 yug., and noradrenaline, 5.2
yug. per litre of peripheral venous blood were reported
by Weil-Malherbe and Bone (1953) to be average normal
concentrations in healthy human subjects. However,
Weil-Malherbe reported in 1955, in a personal communica¬
tion to the author, that normal values for blood adrena¬
line and noradrenaline concentrations as estimated in his
laboratory were now found to be somewhat lower than those
figures published in 1953. He attributed this to modifi¬
cations to the photofluorimeter and to (unspecified)
changes in the anticoagulant solutions employed.
Manger et al. (1953) described the use of sodium
thiosulphate for its differential effect on the fluores¬
cence of adrenaline and noradrenaline, enabling separate
estimation of the two amines by the method of Weil-Malherbe
and Bone (1952a). Estimated adrenaline concentrations in
peripheral plasma ranged from negative values (designated
"zero" by these workers) to 0,6 ^ig. per litre, with a
mean value of 0.14 (S.D. t 0.21),
The use of the ethylene diamine condensation method
was also reported by Arcnow and Howard (1955) for the
assay of adrenal venous bloodj the technique was basically
similar to that of Weil-Malherbe and Bone (1953)* but the
use of adsorption columns was discarded, aluiaina being
added directly to plasma extracts, A limited experience
with this technique did not demonstrate to the author
that it held any advantage over the method described in
this thesis which is based on column adsorption,
A description of the ethylene diamine condensation
method, with the modifications employed by the author
for the studies on insulin hypoglycemia, now follows:
Reagents
(1) Alumina. W8elm alumina (aluminium oxide),
non-alkaline, Grade 1 (Alupharm Chemical Co., Elmont,
Long Island) was used without further treatment, and
could be stored without desiccation,
(2) Glas3-distilled water. Enough glass
distilled water was prepared for one week's use to avoid
contamination, and was kept at room temperature in glass
stoppered containers. This water was used throughout
the procedure and in making up all reagents, except where
otherwise stated.
(3) Ethvlenediamine mixture. Sthylenediamine
.21101 was prepared by adding 1 part of freshly
redistilled ethylenediaraine base to 4 parts of absolute
ethyl alcohol, followed by addition of this mixture to
30 part3 of absolute ethyl alcohol containing 10 per cent
concentrated hydrochloric acid. Fifty ml. of base yielded
approximately 115 gm. of the dihydrochloride salt by this
procedure. The precipitated ethylene diamine .2HC1
crystals were then filtered on a Buchner funnel, washed
with small amounts ox absolute ethyl alcohol, dried in
a vacuum desiccator overnight, and used to prepax*e a 2M
aqueous solution as needed. Five parts of the freshly
prepared 2M solution of ethylenediamine 2HC1 and 7 parts
of the freshly redistilled ethylenediamine base were
chilled separately to 4°C, and then carefully mixed so
as to prevent the temperature from rising above 20°C.
The mixture was 3tored at 4°C., and quantities sufficient
for immediate use were removed as needed. This prevented
the gradual increase in fluorescence of blanks and the
decrease in fluorescence of the adrenaline and noradrena¬
line standards, which occurred when the mixture was
stored at room temperature. The use of 1 ml. of this
mixture produced no change in fluorescence from that
obtained with 1.2 ml. as called for in the original method
described by Weil-Malherbe and Bone (1952a).
(4) Sodium acetate. A 2M solution of Merck
reagent sodium acetate was processed through a column
of "Zeo-Rex" to remove contaminating heavy metals
(Zeo-XarbB 215, as used by Weil-Malherbe and Bone, is
unobtainable in America). Two gm, of "Zeo-Rex" were soaked
in water overnight, layered onto small gravel in a
chromatograph column, and washed with 3 litres of 2N
hydrochloric acid, followed by 3 litres of water and
6 litres of 4 per cent sodium chloride. Excess sodium
chloride was then removed with 1 litre of water and the
acetate solution passed through at a rate of about 10 ml.
per minute. The solution was stored in a glass-stoppered
bottle, and diluted Is 10 with water as needed.
(5) Acetic acid. Enough 0.3M acetic acid was
made up to last for approximately one week, and was stored
at room temperature.
(6) Sodium thiosulnhate-sodium fluoride mixture.
A solution containing 30 gm. of sodium thiosulphate
(reagent grade) and 20 gm, of sodium fluoride (reagent
grade) in 1 litre, stored at room temperature.
(7) Sodium chloride. Any reagent grade sodium
chloride was found satisfactory.
(B) Isobutvl alcohol. Merck reagent isobutanol,
labelled "suitable for fluorimetric analysis" was used
without further treatment.
(9) Stock solutions of adrenaline and noradrena¬
line. Solutions of adrenaline bitartrate and noradrena¬
line bitartrate monohydrate in 0.1M acetic acid were
prepared by dissolving 36.3 and 39.6 mg. respectively of
the salt in 100 ml. of 0.1M acetic acid, with further
dilution 1:5000 to obtain solutions which contained 40
. of base per litre. When stored at refrigerator
temperatures, these solutions remained stable for at least
six months as determined by assay with this method.
(10) Permanent standards. Ten ml. isobutyl alco¬
hol extract of 10 ml. of water containing 20 yug. adrena¬
line which had been condensed with ethylene diamine; this
was stored at 4°C. and diluted 1:100 with isobutyl alcohol
for use as required to maintain instrument sensitivity
at a preassigned value (90.0 divisions at diaphragm
opening No, 3) for each secondary filter.
Permanent standards of adrenaline condensate in
isobutyl alcohol were stable for at least six months when
stored at 4°0. Using one dilution of standard, the
readings of blank solution with the yellow filter pair
in position were about 30 per cent of those obtained with
the green filter pair. Since the estimated adrenaline
levels in normal subjects were found to be about 4 per
cent of apparent noradrenaline levels, the use of a
larger galvanometer deflection with the yellow filter pair
appeared justifiable. However, two dilutions of the stan¬
dard could be used to achieve comparable precision of the
galvanometer reading with both secondary filter pairs.
Apparatus
(1) Chromatographic columns. These were made for
the author and are of simple design. A cylindrical bulb
of about 30 ml. capacity is joined at one end to a 10 cm.
length of 7 mm. tubing which has a small constriction
at the opposite end; the other end of the bulb is joined
to a 5 cm. length of 10 mm. tubing. This tube receives
a rubber hose for applications of air pressure during
chromatography, and all solutions are introduced at this
end of the column.
(2) Fluorimeter. A Farrand fluorimeter, with a
Rubicon galvanometer to receive the output of the photo-
multiplier valve circuit, was found to have adeouate
sensitivity for the measurement of the low level of
fluorescence intensity encountered (27). The primary
filter combination consisted of an interference filter
with a peak wavelength of 436 mu plus a Wratten gelatin
filter No. 35. The secondary filter combinations were:
(a) Yellow filter pair, comprising two
Wratten gelatin filters Nos. 57 and 21, with a combined
peak at approximately 560 mu.
(b) Green filter pair, comprising a 500 mji
interference filter plus a Wratten gelatin filter No. 57.
Method
Before investigating the effect of insulin hypo¬
glycemia on the adrenaline concentration in peripheral
blood, the author, while learning the technical procedure,
assisted in a preliminary assessment of the method of
Weil-Malherbe and Bone (1953). Some of the results of
this evaluation will be included here.
The estimation of blood samples was carried out
in duplicate for all the studies described in this thesis
For this purpose, approximately 32 ml. of blood was with¬
drawn into a 30 ml. syringe previously moistened thorough
ly with heparin, 1000 units per ml. (It was previously
established that heparin did not interfere with the
analysis). The blood was transferred to a chilled centri
fuge tube, which was centrifuged at about 300 G. for 20
minutes. The plasma was aspirated, and divided into two
samples, each of & to 10 ml., which were then diluted
with 5 ml. of fluoride-thiosulphate solution. For this
study, the diluted plasma was stored overnight in the
refrigerator at approximately 4°C.
Adsorption columns were prepared by pouring 0.7 gm
of alumina into a column partly filled with distilled
water, allowing the alumina to settle by gravity onto a
glasswool plug previously placed at the constriction. As
the alumina settled, the glasswool was gently tapped with
a glass rod. Five ml. of 0.2M sodium acetate were then
passed through the column until about three quarters of
its volume was filtered.
The diluted plasma was now further diluted with
an equal volume of 0.2M sodium acetate solution (adjusted
to pH £.4). Adjustment of the plasma-acetate mixture to
pH S.4 was not found to be critical. Additions of adrena-
line and noradrenaline to plasma, with and without pH
adjustment, were made in quadruplicate and recovered in
equal amounts; alumina in sufficient quantity acts as an
ion-exchange adsorbant and 0.7 gm. in a column Kill raise
the pH of the effluant by about one pH unit provided 25
per cent of the fluid is plasma (Valk, 1955).
The plasma-acetate mixture was added to the column
and passed through at a. rate of about 30 drops per minute.
Eefore all the plasma had been filtered, 5 ml. 0.2M sodium
acetate were added. This was followed by 5 ml. of water,
which was forced through until the last few drops just
entered the alumina column.
Elution of the adsorbed amines was effected by
passing 5 ml. of 0.3M acetic acid followed by 5 ml. of
water through the column. The eluate was collected in a
50 ml. centrifuge tube, in which all the subsequent
reactions occurred.
In addition to plasma eluates, two adrenaline and
two noradrenaline standards, and two reagent blanks were
run through the condensation procedure. It was found
that when adrenaline standards were prepared for conden¬
sation in 5 ml. of 0.3M acetic acid and 4 ml. of water,
fluorescence intensity was only 60 per cent of that
obtained when these standards were prepared in 9 ml.
"reagent blank solution." ("Reagent blank solution" -
the acetic acid/water eluate obtained from a column
through which reagents or water alone had been passed).
The fluorescence intensity of noradrenaline standards did
not differ under the two conditions of preparation. The
increase in fluorescence of adrenaline condensate was
apparently due to the presence in the eluate of particles
of alumina, and was not due to the reagents used. Use of
water eluates from the alumina column did not increase the
fluorescence of adrenaline condensates, whereas acid
eluates were effective. The mechanism of this catalysis
by alumina was not further studied. In the course of
studies carried out in this laboratory it was found also
that the fluorescence readings for "reagent blank solution"
when water alone was passed through the column were well
within the variation shown by reagent blank solutions
obtained from a column washed with fluoride-thiosulphate,
water and sodium acetate solution (Valk, 1955).
In these studies, therefore, "reagent blank solution"
was prepared by making up the alumina column in the usual
manner and passing through 30 ml. of water. The column
was then eluted. Six reagent blank solutions were used,
two being condensed without addition, the fluorescence
being read as "reagent blank." The other four reagent
blank solutions were used for two adrenaline and two nor¬
adrenaline standards. Standards were used which were only
one-fifth the concentration of those recommended by
Weil-Malherbe and Bone, 1952a,1953). They were prepared
by adding 1 ml. of "stock solution of amines," containing
40 yug. per litre, to 9 ml. of the reagent blank eluate.
The standards were read in the fluorimeter at the same
sensitivity setting as that used for samples from normal
plasma.
The condensation reaction was carried out by-
adding 1 nil. of ethylene diamine mixture to each
centrifuge tube containing eluate. The tubes were
then heated at 50°C. for 20 minutes. Four gm. of
sodium chloride were now added to each tube, followed
by 6 ml. of isobutyl alcohol. The tubes were shaken
mechanically for 4 minutes and briefly centrifuged to
clear the isobutyl layer.
All the tubes received identical time and
intensity of exposure to roomlight or daylight during
and after the condensation. The condensates of adrena¬
line and noradrenaline, and of the reagent blank solu¬
tions, were found to be sensitive to light of wave¬
lengths less than about 500 mjx, and the fluorescence
intensity of all three decreased on prolonged exposure
to either the primary source of the fluorimeter or the
unfiltered Hg-vapour bulb. Fluorescence decay was
measured for all three condensates on a Brush pen
recorder which received the output at peak gain of
the photomultiplier tube via a direct current amplifier.
Decay was almost completely confined to that portion
of the spectrum passed by the green (500 mji.) filter
pair. The noradrenaline condensate decayed exponen¬
tially with time, and although the decay was complete
and irreversible after prolonged exposure, a partial
recovery always ensued if the exposure was of short
duration. Exposure of adrenaline and of reagent blank
condensate for 15 minutes resulted in about 5 and 50
per cent irreversible decay, respectively, but a 10
second exposure produced no measurable decay for these
condensates. Exposure to roomlight, comprising six
40-Watt fluorescent bulbs in reflectors at a distance
of four feet, produced no measurable decrease in fluor¬
escence of the noradrenaline condensate. No increase
in fluorescence of the noradrenaline condensate was
obtained by carrying out the condensation and all sub¬
sequent manoeuvres in red light (Valk, Price and Millar,
1955).
After centrifugation, the tubes were placed in
the dark and assayed fluorimetrically by withdrawing
one tube at a time and transferring 1.5 to 2 ml. of
the isobutyl layer to a cuvette, which was used for all
samples, The cuvette was rinsed with small amounts of
isobutyl alcohol from each successive sample before
transferring the final quantity of the sample to be
read.
With the secondary green filter pair in place in
the fluorimeter and the diaphragm aperture No. 3 in the
primary light path, the galvanometer was set at 90.0
divisions with the permanent standard which had been
diluted 1:50. All samples were first read with the
green (500 my.,) filter pair in position, to ensure
constancy of decay of all the noradrenaline condensates.
With the shutter open, the sample cuvette was quickly
introduced into the light path and the new deflection
noted after an interval of 5 seconds, which was kept
constant for all samples. The same procedure was
followed with the secondary yellow (5&0 mji.) filter
pair in position. With this filter, due to the absence
of fluorescence decay, the time interval prior to read¬
ing did not require to be constant, provided that time
was allowed for completion of the galvanometer swing.
Calculations of plasma concentrations of adrena¬
line and noradrenaline were made by constructing
simultaneous equations involving galvanometer divisions
per ug. of adrenaline and noradrenaline per litre, for
both secondary filter combinations:
Where a - average of galvanometer deflections due to
adrenaline standards.
b - average of galvanometer deflections due to
noradrenaline standards.
c s average of galvanometer deflections due to
reagent blank.
d - galvanometer deflection due to sample.
then A ~ c) + n b - c « d - c
4 4
Two of the above equations were constructed, one
for each secondary filter; they were then solved to
give estimated adrenaline and noradrenaline concentra¬
tion per litre in the plasma sample. If less than 10
ml. of plasma were used for estimation, the figures
obtained were multiplied by 10/volume of the sample,
to give the corrected values in jag. per litre.
Additions of adrenaline, 0.001 to 0.20 jag. t and
of noradrenaline, 0.005 to 4.0 Jag., were made to 10 ml.
samples of human plasma, a total of 36 additions being
made. Average recovery of added adrenaline was 73 per
cent (3.D. +26 per cent and of noradrenaline 30 per
cent (S.D.t 27 per cent).
Recoveries and standard deviations at, and slightly
above the levels of adrenaline and noradrenaline found
in plasma of normal human subjects, are shown on page 107.
The increased standard deviation of recovery at lower
levels of added adrenaline and noradrenaline is not
unexpected since the variation in reagent blanks induced
greater scatter as the level of added amines approached
zero.
On page 303 are listed the dihydroxyphenol compounds
which were added to plasma and tested by the ethylene
diamine condensation method in this laboratory.
Percentage of recovery, and the fluorescence ratio shown
by each compound on the secondary filter are also illus¬
trated. (This comparison was carried out by Dr. A. deT.
Valk, to whom the author is grateful for permission to
include here). It is of interest to note that 5-hydroxy-
tryptamine (serotonin, enterotonin, thrombocytin) is
apparently not adsorbed on aluminium oxide. The fluores¬
cence ratio of 3:4 dihydroxyphenyl acetic acid can be
seen to differ from that shown by noradrenaline by 3.0 per
cent. The possible implication of this will be more
fully considered later.
Plasma levels in normal human subjects
The plasma of twenty-two normal adults was
analysed for adrenaline and noradrenaline in this labo¬
ratory, using duplicate samples. The mean of the
estimated adrenaline levels was 0.09 jUg. per litre of
plasma {S.D, - 0.12) with extremes of -0.14 and 0.32yug.
per litre of plasma. The mean of apparent noradrenaline
levels was 2.66 jag. per litre of plasma (S.D. - 1.12)
with extremes of 0,79 and 5.49 JQg. per litre.
There is suggestive evidence, to be more fully
discussed later, that the fluorescence estimated as
noradrenaline in plasma is produced by one or more other
substances, whose condensation product shows a fluores¬
cence ratio close to, but not identical with that shown
by the condensation product derived from noradrenaline.
Consequently it is suggested that values for apparent
noradrenaline concentration do not represent the true
value for the noradrenaline concentration in peripheral
plasma•
INSULIN HYPOGLYCAEMIA
A short account of the clinical background and
the pharmacological concepts relating to insulin
hypoglycaemia will now be presented.
In 1922, Banting and Best successfully demonstrated
for the first time, in extracts of degenerated and
foetal pancreas, the presence of a substance capable of
reducing the degree of hyperglycaemia and of raising
the carbohydrate tolerance of diabetic (depancreatised)
dogs. Also, they and their associates (Banting et al.
1922a) described characteristic effects of insulin
injection in normal rabbits - hyperexcitability, hunger,
thirst, and fear, progressing to convulsion and coma.
Glucose injection was found to restore the animal to
normal. A preliminary clinical report (Banting jet al.
1922b) showing the action of insulin in lowering the
blood sugar in patients with diabetes mellitus was
followed by a description of the clinical symptom complex
"hypoglycaemia" (Fletcher and Campbell, 1922; Banting
et al. 1923).
Fletcher and Campbell described the state of
hypoglycaemia in these words: "The initial symptom may
be a feeling of nervousness or tremulousness, some¬
times a feeling of excessive hunger, at other times a
feeling of weakness or a sense of "goneness." The level
at which a patient becomes aware of the fall in blood
sugar is fairly constant for that individual, although
this is not always the case ...... the reaction may go
no further than this of its own accord, or it may be
cut short at this stage by the administration of carbo¬
hydrate. More usually it is rapidly followed by
objective signs - most frequently a sweat which may be
very profuse; pallor and flushing are common; sometimes
a change in pulse rate. In children, this increased
pulse rate is often the means of detecting hypoglycaemia;
in adults the sweat is the outstanding feature. At the
same time the subjective symptoms become more severe;
the feeling of nervousness may become definite anxiety,
excitement, or even emotional upset. Some have
complained of vertigo; others of diplopia. This is the
extent of most reactions: much more severe manifestations
are observed with further lowering of the blood sugar.
Marked excitement, emotional instability, sensory and
motor aphasia, dysarthria, delirium, disorientation,
and confusion have all been seen. Syncope or collapse
may occur, rarely going on to a state of unconsciousness.
The blood pressure has fallen in one or two cases, but
more often it is well sustained. Bradycardia has
occurred; convulsions have not been seen.*
In this early clinical report Fletcher and Campbell
suggested, as an effective means of controlling the hypo¬
glycaemia, the injection of adrenaline 1:1000, 1 cc.
Clinical experience quickly began to suggest
certain alterations in cardiovascular physiology during
insulin hypoglycaemia. Thus, in 1923, Gigon reported
the death from cardiac failure of a diabetic patient
who had received three doses of insulin. Reinwin (1929)
observed two patients with diabetes and circulatory
insufficiency, in whom insulin administration appeared
to increase the degree of congestive failure. Cardiac
infarction following insulin administration was report¬
ed by Joslin (192&), and Blotner (1930), while death
during insulin hypoglycaemia occurred in several
patients with coronary artery disease (von Noorden and
Isaac, 1927).
In several instances, insulin hypoglycaemia was
held to be responsible for precipitating an attack of
angina pectoris (Hetenyi,1926; Katz, 1929; Turner, 1930).
Diminished amplitude of the electrocardiographic
tracing, and inversion of the T wave during insulin
hypoglycaemia were other findings (Middleton and Oatway,
1931).
Studies of cardiac output (Lauter and Baumann,
1929), employing the ethyl iodide method of Henderson
and Haggard (1925), showed an increase during hypo¬
glycaemia in one normal subject and five patients with
diabetes mellitus. Ernstene and Altschule (1931),
using the acetylene method of Grollman (1929),
measured the cardiac output in 16 normal subjects.
During hypoglycaemia there was an average increase of
29 per cent in the minute output of the heart. An
increase in pulse pressure occurred, averaging 29 mm.Hg.
(73 per cent); systolic pressure increased 12 per cent,
while diastolic pressure showed a 20 per cent decrease.
Pulse rate increased, on average, by 15 per cent.
As stated by Ernstene and Altschule: "Clinically the
changes in pulse rate, systolic and diastolic pressure and
cardiac minute volume output which occur during insulin
hypoglyeaemia are similar to those that follow subcuta¬
neous administration of epinephrine." (See Jensen, 1930;
Euler and Liljestrand, 1927).
Boothby and Wilder (1923) found that insulin had no
direct effect on the metabolic rate; they suggested that
the increased metabolism recorded during insulin hypogly-
caemia resulted from a spontaneous discharge of epinephrine.
Similar clinical observations were no doubt largely respons¬
ible for the considerable interest shown by pharmacologists
in the physiological changes accompanying insulin hypogly-
caemia.
GlmstejAd and Logan (1923) observed signs of sympathetic
stimulation in cats during insulin hypoglycaemia; Burn (1923)
presented suggestive evidence that ergotamine could enhance
the hypoglycaemic action of insulin in the rabbit, while Burn
and Marks (1925) reported that section of both splanchnic
nerves in the cat increased the hypoglycaemic action of insu¬
lin. Houssay et al. (1924), by cross-circulation experi¬
ments, demonstrated the liberation of an adrenal hormone
during insulin hypoglycaemia. In 1924, Cannon, Mclver and
Bliss demonstrated in cats that the rate of the denervated
heart was increased when the blood glucose level fell.
This effect was not seen if the adrenal glands were first
denervated or removed, although other signs of sympathetic
stimulation persisted, e.g., hair erection and restlessness.
This work was later supported by Ernstene et al. (1935), who
reported their measurements of heart rate and cardiac output
during hypoglycaemia in normal cats after cardiac denerva¬
tion, and following cardiac denervation plus adrenal inacti-
vation (by removal of the right adrenal gland and denerva¬
tion of the left). In the animals with denervated hearts
and intact adrenal glands, insulin hypoglycaemia was accom¬
panied by an average increase of 23 per cent in cardiac
output (measured by the Fick principle with direct arterial
and mixed venous sampling by cardiac puncture (23), and an
increase in the heart rate of 26 per cent. In the animals
with denervated heart and inactivated adrenal glands there
was an average decrease of 10 per cent in cardiac output,
with an average increase in heart rate of only 1 per cent
during insulin-induced hypoglycaemia.
3y histological examination of the adrenal medulla,
a decrease in the chromaffin material was demonstrated in
rats given large doses of insulin (Poll,1925). Similar
findings have been reported by other workers (Gohar,1934;
Ricci and Milani,1925; Hofmann,1926; Kahn,1926; Vogt,1947).
The assay of adrenaline extracts also indicated adrenaline
depletion during insulin hypoglycaemia (Saito, 1929), and
the most recent quantitative estimations by biological
assay have confirmed a fall in the adrenaline content
(Burn et al. 1950; Hokfelt,1951; West,1951; Outschoorn,1952).
Udenfriend et al. (1953) have confirmed this by chemical
assay. An increased adrenaline concentration in adrenal
venous blood was reported by LaBarre and Houssa (1932),
and Yen et al. (1933). More recently, a fall in the adrena¬
line concentration in adrenal venous blood has been demon¬
strated (Durs^r, 1953) during glucose infusion.
Brandt and Katz (1933) found that human blood
possesses adrenaline-like activities during hypogly-
caemia, the blood of control subjects being inactive:
they used as test objects the perfused rabbit ear, the
isolated rabbit ileum, and the enucleated frog eye.
Increased vasoconstriction in the perfused rabbit ear,
produced by human blood withdrawn following insulin
injection, was also reported by Meythaler and Wossidlo
(1935). This was later confirmed (Meythaler et al. 1951),
with the reservation that the response varied according
to the constitutional type of the subject.
A pertinent observation was made by Freeman et al.
(1934) who described the constriction of denervated
blood vessels during hypoglycaemia. Contraction of the
denervated nictitating membrane (Partington, 1936) and
dilatation of the pupil (Abe, 1924; Bender and Siegal.
1939) were also noted. Also, sympathectomised animals
were shown to be hypersensitive to the action of insulin
(Schlossberg et al., 1933).
A rise in the urinary excretion of adrenaline,
after insulin injection, was observed in human subjects
by Euler and Luft (1952). Kalaja and Savolainen (1941),
using their fluorimetric technique, described an increase
in estimated blood adrenaline after insulin administration.
Other workers, in many cases employing less specific
techniques, have described controversial findings in
regard to an anticipated increase in blood adrenaline
content during hypoglycaemia. Stewart and Rogoff (1923)
stated that the action of insulin did not differ in
normal and adrenalectomised rabbits. Heilbrunn and
Liebert (1939), using the frog perfusion technique,
found a variable effect on testing blood obtained from
patients undergoing insulin shock therapy. Shaw's method
(1938) was employed by Tietz ^t al. (1940) and by Tietz
and Birnbaum (1942), who observed little change in the
estimated adrenaline level during the first two hours
after insulin administration. Raab (1943), using the
method of Shaw (193&), found an increased blood content,
during hypoglycaemia, of the chromogenic material esti¬
mated as adrenaline by this method. Richter (ouoted by
Jone3, 1939) using the same method, concluded that
adrenaline was not present in significantly increased
concentration in arterial blood at the period when
hypoglycaemia was clinically apparent.
The most recently reported attempt to utilise
a chemical method for the estimation of plasma
adrenaline during insulin hypoglycaemia was by
Weil-Kalherbe and Bone (1952b) and by Weil-Malherbe
(1953). In the first paper, the authors
60.
employed their method as originally described (1952a),
estimating adrenaline and noradrenaline together as
"blood adrenaline." The 28 human subjects used for the
study were undergoing insulin shock therapy; the insulin
was injected intramuscularly and blood samples were
withdrawn before and at intervals after injection. In
contrast to the well-established pharmacological and
clinical observations during insulin hypoglycaemia,
Weil-Malherbe and Bone described a marked fall in
"blood adrenaline" concentration in peripheral venous
plasma, usually occurring within 30 minutes of intra¬
muscular administration of insulin. The "adrenaline"
level remained below pre-insulin levels (i.e. below
estimated levels of 3 to 4 ug. per litre) during the
period of hypoglycaemia. During hypoglycaemic coma,
1-glutamate, 1-arginine, glycine and succinate appeared
to raise the blood adrenaline concentration, as did
electrical stimulation of the brain. Although no
explanation could be given for the lowered adrenaline
level, Weil-Malherbe and Bone suggested that an increased
rate of utilisation of adrenergic amines by the tissues,
during insulin hypoglycaemia, might be responsible.
Subsequent to the development of the method for differ¬
ential estimation of adrenaline and noradrenaline,
Weil-Malherbe (1953) confirmed these earlier observations(p. 109)
during insulin hypoglycaemia, and stated: "It must be
assumed, therefore, that under the influence of insulin
the fixation of adrenaline in the tissues is increased, and
this has been clearly demonstrated by Hokfelt (1951)."
Hokfelt, employing a combination of chemical and
biological methods of assay, had shown that while the
adrenaline content of the adrenal gland was reduced
after insulin injection, this was accompanied by a marked
increase in the adrenaline content of heart and liver.
In 1954, Holzbauer and Vogt reported their results
obtained by the direct estimation of adrenaline in peri¬
pheral venous plasma during insulin hypoglycaemia. They
employed a highly specific technique involving acid-
ethanol extraction (Vogt, 1952), separation of adrena¬
line and noradrenaline from extracted plasma by paper
chromatography (Crawford and Outschoorn, 1951), followed
by biological assay of adrenaline (on the rat uterus)
and noradrenaline (using the rat blood pressure), (29).
Holzbauer and Vogt were able to demonstrate maximum values
of 1 to 6.4 jig. adrenaline per litre after insulin
injection in two dogs (0.2 to 2.1 units per kg.). In
one human subject studied, the adrenaline concentration
45 minutes after insulin (0.24 units per kg.) was 1.6 jig.
per litre. Although concentrations of noradrenaline
at or above 1 jig. per litre could be recovered by their
method, no noradrenaline was detected in peripheral
venous plasma before, during or after hypoglycaemia.
It is apparent, therefore, that attemptsto use
chemical methods for the estimation of quantitative
changes in adrenaline concentration during insulin
hypoglycaemia have failed to agree with the results
obtained by indirect pharmacological evidence based
on signs of sympathetic stimulation, and on signs of
stimulation of organs previously denervated, and with
good evidence, adequately confirmed, of adrenal medullary
depletion; chemical methods have also failed to confirm
the convincing evidence of adrenaline release obtained
by direct pharmacological assay of peripheral venous
blood.
An attempt was therefore made by the author to
use the ethylene diamine condensation method, modified
as described from the method of Weil-Malherbe and Bone
(1952a, 1953), for the quantitative assay of adrenaline




Six studies were carried out on 4 dogs which,
although not specially trained, had been previously
exercised and fed by the author. On each occasion
they had been fed approximately IS hours prior to the
study,
Blood for sampling (32 ml,) was withdrawn from
any convenient leg vein after superficial infiltration
with xylocaine. Usually two veins were used during the
study, and occasionally the limbs of the dog were
placed in warm water to increase blood-flow. After
withdrawal of a control sample of blood, soluble insulin
was injected intravenously in a dose of 1,7 to 2,4 units
per kg. Three further samples of blood were drawn, and
at a variable time, usually about ninety minutes after
the start of the study, 5 to 6 gm. 25 per cent glucose
were injected intravenously. One or two further blood
samples were subsequently withdrawn during the recovery
period.
From previous studies in dogs it had been found,
using the chemical method of estimation employed in
this study, that there was no measurable rise in the
estimated plasma adrenaline concentration as a result
of the withdrawal of 180 ml. blood, the approximate
amount required for each insulin study.
Human sub.iects
Five healthy male students {ages 21 to 30) were
studied in the morning following an overnight fast.
Each subject was allowed to rest for 10 minutes,
following which, after superficial infiltration with
xylocaine, a wide bore needle with stilette was
inserted into a convenient forearm vein, used for
insulin injection and the withdrawal of blood samples.
Arterial blood pressure was recorded by the auscultatory
method, a reading being taken just before or just after
the withdrawal of a blood sample.
Following withdrawal of the control sample of
blood, insulin was injected intravenously. Three to
four further samples were withdrawn until termination
of the hypoglycaemia by the intravenous infusion of
500 cc. of 5 per cent glucose in water, supplemented
by 25 cc. of 50 per cent glucose.
The three studies during which ballistocardio¬
gram tracings were taken were carried out in a similar
fashion, with the subject lying on a high frequency
Starr ballistocardiograph table.
The blood samples were withdrawn into heparinised
30 ml. syringes which were placed in a container and
surrounded with ice. At the conclusion of a study,
each sample was placed in a chilled 50 ml. centrifuge
tube, and after withdrawal of 1 ml. blood for glucose
determination, the sample was centrifuged for 20 minutes
at approximately 300 g. The plasma from each sample
was aspirated and divided into two portions of 7 to
10 ml. {the volume being noted) which were placed in
clean test tubes to each of which was added 5 nil.
sodium fluoride/sodium thiosulphate solution.
The plasma samples were covered and stored over¬
night at 3°C. The adrenaline estimations were performed
on the day following the study, employing the reagents
and method already described (pages tfO'SZ).
The blood glucose determinations, based on the
colorimetric method of Kelson (1944) were performed on
the day of the study.
The basis of the method of Nelson is that
glucose present in a protein-free filtrate of blood
reduces copper in alkaline solution when heated. The
cuprous copper thus formed reacts with arsenomolybdate
reagent to give a stable blue colour. The colour is
compared with that given by known amounts of glucose.
Reagents
5$ Zinc sulphate.
0.3N Barium hydroxide (22.5 gms./500 ml.) fil¬
tered to remove barium carbonate, and stored in an
aspirator bottle containing a soda-lime tube in the
stopper.
These solutions are diluted 1 to 4, although
the concentrations of zinc sulphate and barium hydroxide
is less important than the fact that they exactly
neutralise each other (this is carefully checked by
titration, with phenolpthalein indicator).
Copper Reagent A.
25 gms. anhydrous sodium carbonate
25 gms. sodium potassium tartrate
20 gms. sodium bicarbonate
200 gms. anhydrous sodium sulphate
Water 1,000 cc.
Copper Reagent B.
15$ copper sulphate solution, to 500 cc.
of which is added 0,25 ml. concentrated sulphuric acid.
Prior to use, the alkaline copper reagent is
constituted by diluting 1 ml. of solution B in a mixing
cylinder to 25 ml. with solution A, the solution being
thoroughly mixed.
Arsenomolybdate colour reagent - 50 gm. ammonium
molybdate in 900 cc. distilled water; 42 ml. concentrated
sulphuric acid; 6 gm. disodium orthoarsenate in 50 cc.
of water. These solutions are mixed and placed in an
incubator for 24 - 4# hours at 37°C., then stored in a
brown glass-stoppered bottle.
Glucose standard solutions - made from a stock
solution containing pure dextrose dissolved in 0.2$
benzoic acid solution, 10 mgm. per ml.J 0.5 ml., 1 ml.,
and 2 ml. of stock solution are diluted to 200 ml. with
benzoic acid solution to give 50 mgm., 100 mgm., and
200 mgm. per cent glucose standard solutions respectively.
Preparation of protein-free filtrate (Somogyi, 1945) - In
a 50 ml. glass-stoppered bottle are placed 9«5 ml., 0.3W
barium hydroxide, 1 ml. of blood for glucose determination
and 9.5 ml. zinc sulphate solution. After vigorous
shaking the solution is filtered.
Determination of blood glucose - 1 ml. alkaline copper
reagent is added to 0.5 ml. of each of the three stan¬
dard solutions and to 0.5 ml. of water for blank solution,
in test tubes. After mixing, a marble is placed on top
of each tube which is heated for 20 minutes in a vigor¬
ously boiling water bath. The tubes are then removed
and placed in water at room temperature for 1 minute.
To each tube is added 1 ml. arsenomolybdate reagent,
followed by 7«5 ml. water. After careful mixing by
inversion, the colour densities of each solution are
measured in a suitable photocolorimeter, using a 540 mp
filter.
A Beckman spectrophotometer was employed by the
author, using the blank solution for the zero setting.
With the reading from the 100 mgm. glucose standard solu¬
tion the folloi-dng calculation gives the blood glucose
concentration in mgms. per cent.
Unknown reading x 100
Standard reading
In preliminary recovery experiments performed by the
author, consistently satisfactory recoveries of 9S - 100$


























































































































































































































































































































































































































































































































































































































































































































































































































The estimated adrenaline and blood glucose levels
for each study are illustrated in Figures 1-11. The
data from which the adrenaline concentrations were
calculated is tabulated in full on pages 110 - 131.
From previous pilot studies it had been established,
using the chemical method of estimation employed in this
investigation, that there was no measurable rise in the
estimated plasma adrenaline concentration as a result of
the withdrawal of 180 ml. of blood, the approximate amount
required for each insulin study. In six studies carried
out on 4 dogs, there was a rise in the estimated epineph¬
rine level in peripheral venous plasma during hypoglycae-
mia from virtually zero (-0.05) to a mean of 2.14 ug. per
litre (range 0.51 to 4.11). Following glucose administra¬
tion, the estimated adrenaline level fell to a mean value
of 0.13 ug. per litre. In the 5 human subjects, the mean
response was from zero (-0.14) to a maximum value of 1.22
ug.per litre epinephrine (range 0.37 to 2.30 ug, per litre),
falling to 0.06 ug. per litre after glucose infusion.
Analysis of variance of adrenaline values for each
study is shown in Table III (p. 132). In all studies,variance
between the means of duplicate samples was significantly
greater than variance within duplicate samples (studies
2-11 inclusive, p. <0.01; study 1, p.<To.02). Within
each study the difference between two adrenaline values
required to achieve significance at the 5 per cent level
(M.S.D.) is shown in Table IV (page 133). Combining the
variance within duplicate samples gives an M.S.D. value
for the entire study of 0.32 ug. per litre.
The apparent noradrenaline values for each study
are shown in Table V (page 134), the numbering of each
sample corresponds to that for the adrenaline values
illustrated in Figures 1 - 11. A consideration of these
values does not reveal any trend toward a definite or
consistent increase or decrease in estimated noradrenaline
following insulin administration, although in 3 studies
(Nos. 1, 4, and 7) "inconsistent" variation between timed
samples was significantly different from variation within
duplicate samples. The mean estimated noradrenaline value
for all studies was 2.32 i 1.34 ug. apparent noradrenaline
per litre.
During hypoglycaemia in the human subjects there was
an increase in systolic blood pressure with a lowered or
unchanged diastolic pressure. An initial increase in
heart rate was usually not maintained. The typical symp¬
toms and signs of hypoglycaemia occurred to a variable
degree in every study. In the dogs, severe muscular
weakness and hunger were obvious features. Generalized
perspiration, palpitation, and vigorous pulsation of the
cardiac apex and carotid vessels were prominent in the
human subjects. Facial pallor was not constant. Weakness,
lassitude, and some degree of mental confusion were noted
10 to 15 minutes after insulin injection, lasting through¬
out the period of hypoglycaemia. The clinical signs of
sympathetic stimulation were much less evident in subjects
4 and 5 than in the other 3 human subjects, and it is of
interest that clinical observation agrees with the estima¬
tion of lower adrenaline concentrations in these 2 subjects.
Subject 5 appeared to be only slightly affected by insulin
30 units, and a second intravenous injection of 10 units
did not markedly increase the severity of symptoms and
signs. One individual, suffering from mild coryza with
nasal congestion, stated that nasal respiration became
much easier during the period of hypoglycaemia.
The administration of 6 per cent glucose (30 to
40 gm.) by intravenous infusion was followed by a rapid
regression of symptoms and signs accompanying hypo¬
glycaemia. Within 30 minutes the human subjects were
able to continue with their normal routine.
As has been stated, ballistocardiographic tracings
were obtained in 3 human subjects during hypoglycaemia.
However, in view of the indeterminate position held by
ballistocardiography in the minds and opinions of both
clinicians and research workers, a short account of this
subject will now be presented.
BALLISTOCARDIOGRAPHY
In 1736 Parry noted in one of his patients that
the body moved in time with the heart beats; he reported
this in 1825. A Scotsman, Gordon (1377), attempted to
record this movement, using a bed suspended from the
ceiling, levers, and a smoked drum. Gordon's work was
noted by Trotter (1377) a*id by Landois (1379), who made
the first clinical observation by describing the typical
record of abnormal amplitude produced by a patient with
aortic regurgitation.
In 1905, Yandell Henderson, apparently unaware of
previous work, reopened the subject, and on the famous
expedition to Pikes Peak with Haldane and Douglas (to
study the effects of altitude) recorded the movement
imparted by a subject lying on a plank supported on
corks. In 1913 Satterthwaite, a New York physician,
also in ignorance of previous work, secured some records
on a smoked drum. In 1922 the first attempt at
electrical recording was made, but the results were
unsatisfactory (Heald and Tucker, 1922).
The German geophysicist Angenheister (1923) pub¬
lished records obtained by placing a seismograph beside
a subject lying on a rigid table. A special chair was
constructed by Abramson in 1933» but difficulties were
increased by having the subject in the vertical position.
Despite these early efforts, no real advances in
technique or clinical application occurred until Starr
and his associates (1939) reported their original
investigations. Much of the current knowledge regard¬
ing the physical and physiological aspects of ballisto¬
cardiography results from studies subsequently carried
out by Starr in Philadelphia. He and his associates
constructed a "high frequency" table; the records taken
from subjects were called "ballistocardiograms." A
subject lying on the table was free to move only in
his longitudinal dimension, the movement in this
direction being opposed by a strong spring. The move¬
ment was magnified by a light beam system and photo¬
graphed. The modern resisted table employs an electric
pick-up and amplification system, recording by a direct
writer; for the studies on insulin hypoglycaemia and
for the infusion experiments, the Starr table was
utilised.
Newton's third law of motion states: "for every
action there is an equal and opposite reaction."
Wave H is due to a small headward movement of
the body caused by the movement backward of the heart
and blood within it in the isometric period of systole*
Wave I is due to a sharp recoil of the body feet-
ward as the blood is ejected into the aorta.
The J wave indicates the headward movement caused
by the recoil of the aorta as the blood flows down the
descending aorta.
The feetward wave K is produced by the decelera¬
tion of the column of blood in the thoracic and abdom¬
inal aorta.
The other tfaves, L, M, and N are after-vibrations
occurring during systole.
The basic equation from which the analysis of
the ballistocardiogram was initially derived was the
Newtonian equation for force.
By a combination of theoretical reasoning and
empiricism, a series of formulae were devised. In
1942, Cournand et al., selecting one of these, found
that estimation of cardiac output gave results 1#.5 per
cent lower than comparable estimates based on the Fick
method, employing cardiac catheterisation. Nickerson
et al. {1947)| who used a differently constructed
"low-frequency" table allowing free movement of the
subject in the longitudinal dimension, with a different
formula for calculation of cardiac output, obtained
fair agreement between such estimates and those using
the Fick method.
However, although many formulae were subsequently
suggested and employed, doubts were entertained with
regard to the accuracy of estimation of cardiac output
in patients with abnormal ballistocardiograms.
As suggested personally by Starr the following
formula, No. 12 (Starr, 1955) modified from Tanner
(1949), was used by the author in the studies described
for the estimation of cardiac stroke volume;
Stroke volume = 27 X S.A. J (21+ J) JC + 10
where S.A. s surface area in square metres.
I and J s area of ballistocardiographic
waves in millimetre seconds when I mm. deflection
equals 28 gm. force. Each wave is considered as
a triangle, the area therefore being 1/2 (base)
X height.
C s duration of the cardiac cycle in seconds.
Starr (1955) has stated; "when body surface area
or age is introduced into a regression equation includ¬
ing Tanner's formula the accuracy of the estimate is
improved. The error is less than 10 cc. in two-thirds
of the estimates; if the data of the most arterio¬
sclerotic case are omitted this error falls to 8 cc.
The error in the detection of changes of stroke volume
in single persons is considerably less than this, and
the method seems ideal for estimation of changes of
cardiac output due to drugs and other physiological
agents. When the ballistocardiogram is abnormal in
form the estimate by these formulae may give a correct
result, but sometimes the result is low. On the basis
of present knowledge, clear directions cannot be given
which will separate the abnormal records which can
properly be made the basis of an estimate of stroke
volume, from those which should not be used for this
purpose. This is a serious drawback to the routine
use of the ballistic stroke volume method in the clinic,
where so many of the older patients have ballistocardio¬
grams to some degree abnormal in form."
Although the clinical application of information
derived from ballistocardiographic records is a contro¬
versial subject, it is generally agreed that the
ballistocardiograph measures cardiac force. For the
evaluation of pressor drugs and other agents which
affect the force of cardiac contraction, ballisto¬
cardiograph records should hold an important place.
The circulatory data obtained from subjects 3, 4,
and 5 is summarised in the Tables on page 137 and was
reviewed by Dr. Isaac Starr, whose cooperation and advice
the author wishes to acknowledge with gratitude. The
view expressed by Dr. Starr (1956) that the records
closely resembled those obtained during infusion of
1-adrenaline, is based on the increase in cardiac force
clearly evident in the records (pages/^5"), and on the
-HO
estimates of cardiac stroke volume obtained by calcula¬
tion (page 137). During insulin hypoglycaemia, there¬
fore, when the adrenaline concentration in peripheral
venous plasma is increased, as measured by the ethylene
diamine condensation method, there is at the same time
an increase in cardiac force and systolic blood pressure
and a decrease in diastolic pressure, physiological
changes which closely resemble those attributed to
adrenaline by other workers (Goldenberg at al. 194$;
Barcroft and Starr, 1951)•
At the conclusion of these studies on insulin
hypoglycaemia in human subjects, it also seeraed of
interest to attempt a "physiological calibration," i.e.
the correlation of known amounts of 1-adrenaline,
infused intravenously, with plasma levels of adrenaline
as estimated by the ethylene diamine condensation method.
Two studies were carried out by the author, using
subjects 3 and 4 of the insulin study (pages 13$ - 143).
"Suprarenin" brand of 1-epinephrine tartrate
containing 1 mg. adrenaline base per ml. was employed.
An electrically driven shaft, coupled to a 50 ml.
syringe and accurately calibrated to deliver infusion
rates of 1 to 4.5 ml. per minute was used^ 1-adrenaline
was added to normal saline solution to give concentra¬
tions of 1 or 2 ug. per ml. A forearm vein was used
for infusion, blood samples being withdrawn from the
opposite arm. Arterial blood pressure, estimated by
auscultation, and ballistocardiographic tracings, were
recorded at the time of withdrawal of samples, with the
infusion still running. Plasma samples were not with¬
drawn until equilibrium had apparently been reached
between infusion, tissue uptake, and diffusion or
destruction of adrenaline, as judged by the maintenance
of steady blood pressure readings.
The results of the two studies are shown on pages lt+X-Uf-3.
The findings are of considerable interest in that they
give some indication of the adrenaline concentration in
peripheral venous plasma at which physiological effects
are present. The infusion of 1 yug. per minute, 0,01 yug.
per kg. per minute, produced no change in systolic
blood pressure, although the diastolic pressure fell and
there was an increase in pulse rate; the estimated
adrenaline level in peripheral venous plasma was 0.04 yug.
per litre, 2 yug, per minute, 0,04yug. per kg, per minutet
administered to the other subject had little apparent
effect on the circulation, although the estimated adrena¬
line concentration, 0.42yug. per litre, was higher than
that produced by infusion of 3yug. per minute. This is
difficult to explain, but may well be attributable to
variations in recovery of adrenaline by the method of
estimation.
When an infusion of 3 yug. per minute was employed
(0.06 and 0.04yug. per kg. per minute), both subjects
showed well marked increases in systolic pressure and
pulse rate, with a fall in diastolic pressure. These
features, together with the ballistocardiographic records,
which indicated an increase in cardiac force, as previous¬
ly described by Barcroft and Starr (1951)» were closely
similar to those observed during the studies on insulin
hypoglycaemia in the same subjects. The adrenaline con¬
centrations in peripheral plasma in the two subjects
infused with 3 jag» 1-adrenaline per minute (0.25 and 0.34
fxg. per litre) were in fair agreement.
It may be hazardous to draw conclusions from these
restricted data. However, the suggestion could be made
that a level of 0.3 to 0.5 yug. adrenaline per litre of
peripheral venous plasma may be required before definite
physiological effects are apparent. It Is of interest
that the infusion of 0.04 and 0.06 jig, per kg. per minute
(corresponding to 3 jag, per minute in the two subjects
studied), is in the same range as that reported by several
workers for the normal "resting" output of adrenaline from
both adrenal glands (Wada and Kanowoka,1935i Kaindl and
Euler, 1951; Duner, 1953; Houssay and Rapela, 1953).
It was recently reported by Ludemann (1955) that
following the rapid intravenous injection of 450 jug.
adrenaline, the concentration in peripheral arterial
blood fell rapidly to control levels within 2 minutes
45 seconds. Although It is currently believed that there
is a "resting" secretion of adrenaline from the adrenal
medulla, the liberated adrenaline is probably rapidly
destroyed by amine oxidase, catechol oxidase, or other
enzymes, or inactivated by tissue diffusion. To pro¬
duce and maintain effects on cardiac output and blood
pressure may require a rate of secretion of adrena¬
line into the adrenal veins other than the 0.04 to
0.06 jag. per kg. per minute required to produce the
same effects when infused into the antecubital vein.
An infusion of 6 ^ig. per minute (0.11 jxg. per kg.
per minute) produced the typical gross circulatory
effects of adrenaline, vrith an increase in arterial
blood pressure to 136/62 and an estimated adrenaline
level of 1.40 jug. per litre. Although many factors
may be concerned in the regulation of blood pressure
during insulin hypoglycaemia, it is of interest that
in the same subject a comparable blood pressure,
130/50, was accompanied by an estimated adrenaline
level of 1.10 jig, per litre.
In summary, it can be stated that the blood pressure
changes and the ballistocardiographic records obtained
both during hypoglycaemia and during infusion of
1-adrenaline provide substantial support for the
presence of an increased level of adrenaline in peri¬
pheral venous plasma in the range of concentrations
as estimated by the ethylene diamine condensation method,
during the hypoglycaemia induced by insulin.
DISCUSSION
and an appraisal of the
ethylene diamine condensation method
The need for an accurate and specific method for
the chemical estimation of adrenaline in blood has been
appreciated for 50 years, although attempts to use chemi¬
cal techniques for blood analysis have failed to agree
with the results obtained by more specific methods of
biological assay. The two distinct problems involved -
the preliminary separation of adrenaline from interfering
substances in plasma, and the necessity for an adequately
sensitive and specific method of colorimetric or fluori-
metric estimation - have appeared insurmountable. It is
clear that before chemical methods can be accepted and
employed in the pharmacological and clinical laboratory,
they must either agree with established physiological
concepts, or prove convincingly that they are in error.
Although a substantial body of pharmacological
evidence supports the occurrence of adrenaline secretion
during hypoglycaemia, this has been challenged by results
obtained with the ethylene diamine condensation method
(Weil-Malherbe and Bone, 1952b; Weil-Malherbe, 1953). In
the course of a general evaluation of the method of
Weil-Malherbe and Bone (1952a, 1953) the author embarked
on an attempt to estimate adrenaline concentrations in
peripheral venous plasma following the administration of
insulin; several possible results might thereby accrue.
If successful, the study would confirm, for the first time
by a chemical method of blood analysis, the established
concept of an increased adrenaline blood content during
hypoglycaemia; for comparison, there would be available
the data obtained by the direct estimation of adrenaline
in peripheral venous plasma by means of a specific
technique based on biological assay (Holzbauer and Vogt,
1954). At best, a successful result would instil confi¬
dence in the reliability of the ethylamine diamine method;
if unsuccessful, something would be learnt which might
offer an explanation for the contradictory results
achieved with the ethylene diamine method by Weil-Malherbe
and Bone (1952b). At worst, the method might be finally
discarded as a means of estimating adrenaline in peri¬
pheral blood.
With this in mind, the ethylene diamine condensation
method as employed for the studies described in this thesis
will be reconsidered.
The use of aluminium oxide or hydroxide appears to
assure adecuate specificity for the adsorption from plasma
of dihydroxyphenyl derivatives (Shaw, 193^; Raab, 1943;
Lund, 1949c; Weil-Malherbe and Bone, 1952b; Manger et al,
1954; Aronow and Howard, 1955; Ludemann et al. 1955; von
Euler and Orwen, 1955).
The condensation reaction with ethylene diamine
(Natelson et al. 1949) on which the method of Weil-Malherbe
and Bone depends, requires the presence of the catechol
nucleus. From the number of possible interfering substan¬
ces listed on page I0&, it is apparent that two compounds
must be closely considered, viz. 3:4-dihydroxyphenyl-
acetic acid (catechol acetic acid) and hydroxytyramine
(dopamine).
Recently published work by von Euler and Floding
(1955) suggests that catechol acetic acid is responsible
for the greater part of the fluorescence produced by the
condensation of alumina eluates of urine extracts with
ethylene diamine. The biologically active catechol
amines - hydroxytyraraine, adrenaline and noradrenaline -
were found by Euler and Floding to account for only a
small fraction of the total catechol compounds present in
urine.
In recovery experiments carried out in this labora¬
tory (Yalk, 1956; page 108), catechol acetic acid, when
condensed with ethylene diamine, was found to have a
fluorescence ratio (on the two secondary filters) which
differs from that shown by noradrenaline by 10$ or less.
From a comparative assay of plasma samples obtained from
dogs during haemorrhagic shock, by the ethylene diamine
method and by the method of Lund (1950), carried out in
this laboratory (Valk and Price, 1956), adrenaline values
as estimated were found to be in excellent agreement -
1.7$ pg/litre by the ethylene diamine method, l.$4
^ug/litre by Lund's method. Estimated noradrenaline
levels by the latter technique, however, were only 30%
of those attributed to noradrenaline by the ethylene
diamine condensation method. The method of Lund (1949c;
1950) requires the formation of fluorescent trihydroxy-
indole derivatives from adrenaline and noradrenaline
(pagel02). Catechol acetic acid is incapable of indole
ring closure, as can be ascertained from the requirements
listed on page 31, and would therefore escape detection
by the method of Lund.
If present in peripheral venous blood, catechol
acetic acid would be responsible for part of the fluores¬
cence attributable to noradrenaline by the method of Weil-
Malherbe and Bone. Furthermore, since the method uses
adrenaline and noradrenaline standard solutions for the
construction of a simultaneous equation for each secondary
filter used, the presence of catechol acetic acid in
plasma eluates would have the effect of introducing an
error, constant or variable, into the estimation of
adrenaline concentration.
This suggests that methods based on condensation of
plasma eluates with ethylene diamine are insufficiently
specific for the estimation of noradrenaline in blood.
This is confirmed by the work of Holzbauer and Vogt (1954),
who failed to detect any noradrenaline in peripheral
venous blood in 2 dogs and one human subject, although
the sensitivity of their specific biological method
allowed the estimation of 1 ^ig. noradrenaline per litre.
It should be emphasised that no conclusions have been
drawn from the apparent noradrenaline values estimated
in the course of the studies on insulin hypoglycaemia.
Hydroxytyramine has been identified in urine
(Holtz et al. 1942; Holtz et al» 1947; Euier et al.1951),
in adrenal extracts (Goodall, 1950a; Shepherd and West,
1953)i and in mammalian heart (Goodall, 1950b). The
fluorescence ratio produced by hydroxytyramine (1.13) on
condensation with ethylene diamine is close to that of
adrenaline (0.5&) (Valk, 1956; page 108). Although the
presence of hydroxytyramine in blood has not been demon¬
strated, and while its biological activity is weak in
comparison with that shown by adrenaline, the possibility
exists that it may act as an interfering substance in the
estimation of low plasma levels of adrenaline by the
ethylene diamine condensation method.
By the method of Lund, hydroxytyramine produces
only a weak fluorescence (Euler and Floding, 1955). The
formation of fluorescent trihydroxyindole compounds
appears therefore to be more specific for adrenaline and
noradrenaline than is the ethylene diamine condensation
reaction. It should be mentioned, nevertheless, that the
method of Lund allows the estimation of isopropylnor-
adrenaline, recently tentatively identified in very small
amounts in adrenal extracts (Lockett, 1954). With the
ethylene diamine method, isopropylnoradrenaline appears
to have a closely similar fluorescence ratio (0.73) to
that of adrenaline (O.56) (Valk 1956; page 106), but until
its presence in tissue extracts or body fluids is confirm¬
ed, its possible role as an interfering substance can
hardly be considered.
Discussion of Results
Preliminary use of the ethylene diamine condensation
method (Weil-Malherbe and Bone, 1953) indicated an average
adrenaline concentration in ambulant human subjects of
1.32yug. per litre of peripheral venous plasma. Subse¬
quently, other workers have reported normal levels of
0.14 t 0.21 (Manger et al. 1954) and 0.4 - 0,2 (Aronow et al,
1956) jug. per litre. In this laboratory, estimations on
ambulant normal volunteers have indicated an average
level of 0.097 - 0.14 jUg. adrenaline per litre.
In this study on insulin hypoglycaemia, with each
human subject at complete physical rest and apparently
at ease, virtually no adrenaline was detectable in peri¬
pheral venous plasma, prior to insulin injection.
Holzbauer and Vogt (1954), employing a specific technique
based on the biological assay of adrenaline on the rat
uterus, found less than 0.06^Ug. per litre in one human
subject at rest; in two trained dogs, normal levels were
below 0.25 jig, per litre. Following insulin administra¬
tion in dogs, the maximum adrenaline concentrations
(0.51 - 4.11 pg. per litre) as estimated in this study
are closely comparable with the range of maximum values
found by Holzbauer and Vogt (1 - 6.4 jig* per litre). Also
their figure of 1.$ jug. per litre, obtained in one human
subject, falls within the range of maximum adrenaline
concentrations (0.37 - 2.30 ^ig. per litre) estimated in
the 5 human subjects used during this study.
For the quantitative estimation of adrenaline
release during insulin hypoglycaemia, therefore, there
appears to be good agreement between a specific method
based on biological assay and the fluorimetric technique
based on condensation with ethylene diamine. Further
support for the presence of an increased level of
adrenaline, in the range of concentrations as estimated
in peripheral venous plasma during hypoglycaemia has been
provided by the blood pressure changes and ballisto¬
cardiographic records obtained both during hypoglycaemia
and by infusion of 1-adrenaline•
An outstanding issue, since the first use of the
ethylene diamine method {Weil-Malherbe and Bone, 1952a,
1953), has been the disparity between normal plasma
values of adrenaline and noradrenaline as estimated by
this chemical method and by established methods of
pharmacological assay (e.g. Holzbauer and Vogt, 1954).
An explanation for the high "normal" levels of adrena¬
line (1 - 1.5 Jig. per litre) and noradrenaline (5 jug,
per litre) in peripheral venous blood, reported by
Weil-Malherbe and Bone (1953) has not been and is not
available; these high "normal" levels are especially
controversial in view of the much lower "normal" values
of adrenaline determined by other workers utilising a
basically similar method (Manger et al. 1954; Valk and
Millar, 1955; Aronow, 1956).
The controversial findings reported by Weil-Malherbe
and Bone (1952b,1954) and Weil-Malherbe (1953, 1955b) in
regard to decreased adrenaline levels during insulin hypo-
glycaemia have not been substantiated by the author's
studies reported in this thesis. Since the apparent normal
adrenaline levels estimated by Weil-Malherbe and Bone
(1953) are 1 - 1.5 pg. per litre, it is possible that a
true rise in adrenaline concentration after insulin in¬
jection would be concealed, which implies that the apparent
adrenaline estimated by these workers is in fact another
substance. Apart from the statement of his own results, the
author is unable to provide an answer to the question asked
by pharmacologists and expressed in a recent annotation
(British Medical Journal,1956) on the nature of the sub¬
stances estimated as adrenaline and noradrenaline by the
ethylene diamine method employed by Weil-Malherbe and Bone.
The occurrence of negative values for adrenaline.
This has been a disturbing feature, recurring on several
occasions in the course of the adrenaline estimations per¬
formed by the author for the studies described in this
thesis. Since the calculation of adrenaline and nor¬
adrenaline concentrations in plasma samples depends on
the solution of simultaneous equations based on the
relative fluorescence of ethylene diamine condensates
of plasma eluates and adrenaline and noradrenaline
standard solutions, the occurrence of occasional
negative adrenaline values may be regarded as intrinsic
to the method of calculation. Variations in the fluores¬
cence of reagent blanks and, as already mentioned, the
probable existence in plasma eluates of a substance the
fluorescence ratio of which is close to but not identical
with that shown by noradrenaline, are other factors
which may play a part in the estimation of negative
values for adrenaline.
However, substantially negative values for adrena¬
line appear to be due to the introduction during the
technical procedure of non-specific contaminating sub¬
stances, in that their fluorescence spectra are
revealed predominantly on the green 500 my secondary
filter. In fluorescence ratio, therefore, these sub¬
stances to some extent resemble noradrenaline. The
presence of non-specific contamination in control
samples is shown by high fluorescence readings on both
secondary filters, by very high apparent noradrenaline
values, and by substantially negative adrenaline values,
e.g. samples la and lb of study 1 (page111); sample lb
of study 8 (page 125); sample 5a of infusion 2 (page 141).
While it seems certain that such spurious fluores¬
cence indicates contamination, the nature of this
contamination has not been established; consequently, no
values have been discarded from these studies, and the
90.
temptation to call the negative adrenaline values "zeroM
has been rejected. In consequence, the unfortunate effect
produced by taking the mean estimation of a contaminated
and non-contaminated plasma sample has been brought to
the fore,e.g. samples la and lb of study 8; sample 5a and 5b
of infusion 2, page 141.
It is possible that non-specific contamination may be
produced by a substance released from plasma under certain
conditions; such a substance, if adsorbed on aluminium
oxide and carried into the plasma eluate, might be respons¬
ible for spurious fluorescence. For adsorption on alumina
and condensation with ethylene diamine, the substance would
reauire to be a dihydroxyphenyl derivative, and it could
be argued that it might be a degradation product of adrena¬
line or noradrenaline released in plasma before adsorption,
or formed during the adsorption procedure. The necessity
for scrupulous attention to cleanliness of all glassware
is clearly inherent in the satisfactory performance of any
fluorimetric method for the estimation of minute amounts
of an endogenous chemical substance. In the laboratory
employed by the author, all glassware was thoroughly
cleaned with 10% dichromate/sulphuric acid cleaning
solution, washed with tap water several times, and finally
rinsed out with distilled water, before drying in an
electrical oven. These cleaning procedures, and all the
technical procedures involved in blood glucose and
blood adrenaline estimations, were carried out person¬
ally by the author.
Negative adrenaline values, as estimated from the
mean of contaminated and non-contaminated duplicate
control samples of plasma withdrawn during the insulin
studies,may suggest that the subsequent measurement of
zero levels of adrenaline indicates a quantitative
increase in adrenaline concentration. This is very
questionable unless both samples show negativity, e.g.
samples la and lb of study 4 (page 111), in which sub¬
stantially negative values for adrenaline also occur
in the final samples 5a and 5b. In this case it appears
likely that the estimation of a mean value of 0.52 jug
adrenaline per litre in sample 2 indicates an increase
of 0.78 jug adrenaline per litre.
The analysis of variance of apparent noradrenaline
values (Table VjM shows that variation between timed sam¬
ples (which could be accounted for by catechol acetic
acid or by non-specific contamination) was not signifi¬
cantly different from variation within duplicate samples
except in the case of 3 studies (Nos. 1, 4 and 7). In
study 7 (pagel3W it is very suggestive that non-specific
contamination was responsible for the high apparent
noradrenaline value for sample 2; estimated noradrenaline
values for the other samples in this study agree quite
consistently throughout the study. In study 1 (page!3^)
the variation is inconsistent, while in study 4 there is
a marked fall in apparent noradrenaline in the final two
samples. It is clear from the analysis of variance
(pages 135 - 136) that the ethylene diamine method (as
employed for these studies) is ouite inaccurate for the
estimation of apparent noradrenaline, apart from the
fact that it is almost certainly non-specific for the
determination of the true noradrenaline value in plasma
samples.
This discussion has also emphasized the disturb¬
ing features of negative values for adrenaline as
estimated in control samples. Where samples contain
considerable quantities of adrenaline, however, the
presence of contamination does not necessarily affect
the estimated adrenaline value. In samples 3a and 3b
of study 6 , for example (page 121), the adrenaline
values as estimated are in close agreement (3.$0 and
3*95 ug. per litre) while the noradrenaline values differ
considerably (1.33 and 4.71 ug. per litre) (page 134).
Saip^ls 3a and 3b of study 4 present similar features>
noradrenaline values of 7.01 and 4.07 ug. per litre
being matched by adrenaline values of 0.53 and 0.76 ug.
per litre (page 117).
This suggests that when adrenaline is present in
a "contaminated" plasma sample, its presence can still
be revealed accurately, within the limits of each
individual study.
An important factor affecting accuracy is the
wide variation in recovery at low plasma levels of
adrenaline (pagelOl). In the case of duplicate plasma
samples where one sample shows a higher adrenaline
value, it seems likely that the lower value results
from inadequate recovery. Although the standard devia¬
tion of recovery is wide, the available literature does
not record figures for recovery of adrenaline at these
low levels by a chemical method. (Another factor
affecting accuracy and limiting sensitivity at low
levels of adrenaline is the variation in fluorescence
of reagent blanks and standard solutions).
From the author's experience, the likelihood is
not great that the ethylene diamine condensation method,
as described for these studies, overestimates the true
adrenaline level. Furthermore, the values for adrenaline
estimated during the studies described have not been
corrected for the 20% loss during adsorption of catechol
amines on a column of alumina.
It is probable that the estimation of zero or
negative adrenaline values does not preclude the exist¬
ence of small amounts of adrenaline in plasma samples.
This is supported by a consideration of the minimum
significant changes in adrenaline level for each study,
shown in Table 4_V, and from the figure of 0.32 ^ug
adrenaline per litre for the entire study.
For the estimation of small changes in adrenaline
concentration, for the accurate assay of adrenaline
values close to zero, for the determination of absolute
levels of adrenaline in peripheral venous plasma, the
ethylene diamine method does not appear sufficiently
accurate. However, from a consideration of the values
for the minimum significant change in adrenaline
concentration throughout studies 10 and 11 (0.13 and
0.07yug per litre respectively), the possibility cannot
be excluded that in favourable conditions minimal
changes in adrenaline concentration could be convincing¬
ly detected by this method.
In face of the limitations of the ethylene diamine
method for the estimation of plasma levels of adrenaline
close to zero, and of the probable existence in peri¬
pheral venous blood of contaminating catechol degrada¬
tion products such as 3:4 dihydroxyphenyl acetic acid,
it is possible that the ethylene diamine reaction,
because of its excellent sensitivity, may in the future
find more useful application in the pharmacological
laboratory for the estimation of adrenaline and nor¬
adrenaline when these substances can be separated from
plasma by means of paper chromatography.
From the results obtained in the studies described
in this thesis, it is concluded that although the
ethylene diamine condensation method is inaccurate and
95.
non-specific for noradrenaline, it can be suitably
employed for the quantitative estimation of moderate
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Ethylene diamine condensation reaction
































































Weil-Malherbe and Bone (1952a)
Figure 16 (cont'd.)
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o ■0 $ change in glucose conc.




Sample No. Volume (ml.) 530 mp 500 mu
la 10 21 67
b 10 20 63.5
2a 10 17 51
b 10 16 49
3a 3.5 20 56
b 3.5 22.5 69
4a 10 22 56
b 10 23 53
5a 10 13 54
b 10 17 50
6a 10 16 47
b 10 16 45
Reagent blank 13.5 41.75
4 A 47.25 60
4 N 22.5 66.5
530 3.4375 A + 2.25 N =
500 4.5625 A + 6.1375 N = (Factor = 2.75)
530 23.2031 A + 6.1375 N =
13.6406 A = (530 x 2.750) - 500.
N.B. Before construction of equations the reagent
blank fluorescence values are subtracted from the
fluorescence readings of adrenaline (4A) and








No, 5S0 nyu 500 up pg/litre
la 7.5 25.25 -O.24SI -0.36
b 6.5 26.75 -0.4761
2a 3.5 9.25 0.0201 0
b 2.5 7.25 -0.0201
3a 6.5 14.25 0.22SS 0.04
b 9.0 27.25 -0.157S
4a a.5 14.25 0.4S95 0.51
b 9.5 16.25 0.5297
5a 4.5 12.25 0.0067 0.04
b 3.5 S.25 0.073S
6a 2.5 5.25 0.0S72 0.14







Sample No. Volume (ml.) 5&0 bji 500 m
la 9 13 55
b 9 15.5 50
2a 9 23.5 62
3a 9 31.a 65
3b 9 26 55
4a 9 27 62.5
b 9 26 62
5a 9 26.5 70
b 9 21 5^
6a 9 19.5 55
b 9 21 60.5
7a 3 16.5 52
b 3 13 43
Reagent blank 12.25 39.25
4 A 44.5 61.75
4 N 23.25 72.5
530 3.0625 A + 2.75 N =
500 5.625 A + 3.3125 W = (Factor = 3.023)
530 24.3729 A + S.3125 N =
IS.743 A . (500 x 3.023) - 530.
STUDY 2.
Net fluorescence Estimated Mean of the
after subtraction adrenaline duplicate




No* 5&0 ir500 mp pg/litre yug/litre
la 5.75 15.75 0.0963 0.02
b 3.25 10*75 -0.0549
2a * 11*25 22*75 0.6672 0.67
3a 19.5 25.75 1.9674 1.75
b 13.75 15.75 1.5300
4a 14-75 23.25 1.2647 1.19
b 13.75 22.75 1.1151
5a 14.25 30.75 0.7307 0.59
b 3.75 13.75 0.4564
6a 7.25 15.75 0.3654 0.34
b 3*75 21.25 O.3O82
7a 4.25 12.75 O.OO65 -0.05
b 0.75 3.75 -0.0939
* Plasma volume insufficient for duplicate sample
STUDY 3.
Plasma Flu ore scence
Sample No. Volume (ml.) 530 mix 500 m
la 3 16 46
b 3 15.5 44.5
2a 9 17.5 46
b 10 19 50
3a 9 26 53.5
b 3 31 63.5
4a 10 30 57
b 3 27 56.5
5a 10 20 49
b 9 19 47.5
6a 10 19 50
b 9 17 46
Reagent blank 12.72 33.41
4 A 39.5 55.75
4 N 22.5 61.5
530 6.695 A + 2.445 N «■
500 4.335 A + 5.7725 N = (Factor = 2.361)
530 15.3069 A + 5.7725 N =






































Sample No. Volume (ml.) 530 rma 500 mji
la 3 23.5 71
b 3 21.5 6?
2a g 27.5 74
b 7.5 27 70.5
3a 9 32.5 36
b 9 23.5 71
4a g 20.5 55.5
b g 21 55.5
5a 9 20.5 64
b 9 19 60
Reagent blank 16 46.75
4 A 45 61.5
4 N 24.25 70.5
530 7.250 A + 2.0625 N *
500 3.6375 A + 5.9365 N = (Factor = 2.£79)
530 20.37275 A +5.9375 N =






No. 530 mji 500 tcjx
la 7.5 24.25 -0.1933 -0.26
b 5.5 20.25 -0.3213
2a 11.5 27.25 0.4261 0.52
b 11 23.75 0.6144
3a 16.5 39.25 0.5337 0.65
b 12.5 24.25 0.7539
4a 4.5 3.75 0.3059 0.36
b 5.0 3.75 0.4106
5a 4.5 17.25 -0.2777 —0.29
b 3 13.25 -0.2933
Estimated







Sample No. Volume (ml.) 530 iji 500 mji
la 7 17 59
b 7 20 57
2a 5.5 16 46
b 5 21 57
3a 8 43.5 73
b 7 40 69
4a 8.5 36.5 71
b 3 41 37
5 9 21 62
Reagent blank 13 41.25
4 A 44.75 63
4 N 27.5 35
530 7.9375 A + 3.625 N =
500 5.4375 A + 10.9375 N = (Factor = 3.017)
530 23.9474 A + 10.9375 N =















550 rap 500 mji pc/litre jag/litre
la 4- 17.75 -0.4356 -0.01
b 7 15.75 0.4144
2a 3 4.75 0.4226 0.66
b 5 15.75 0.9062
3a 30,5 31.75 4.0699 4.11
b 27 27.75 4.1451
4a 23.5 29.75 2.6154 2.62
b 25 45.75 2.6153
5* 5 20.75 0.2032 0.20
Insufficient plasma volume for duplicate sample.
STUDY 6.
Plasma Fluorescence
Sample No. Volume (ml.) 530 rati 500 mti
la 9 17.5 53
b 9 16 50
2a 9 25 57
b 3 25 53
3a 3 30.5 60.1
b 3 37 30
4a 10 35 64.5
b 9 34 64
5a 9 13.5 52.5
b 9 13 50.5
Reagent blank 13.5 41.25
4 A 32.3 56
4 N 22.25 70
530 4.325 A + 2.133 N =
500 3.633 A + 7.133 N = (Factor s 3.235)
530 15.350 A + 7.133 N =

















la 4 11.75 0.1270 0.04
b 2.5 3.75 -0.0491
2a 11.5 15.75 2.0124 2.09
b 11.5 16.75 2.1613
3a 17 13.35 3.3024 3.33
b 23.5 33.75 3.9516
4a 21.5 23.25 3.3955 3.99
b 20.5 22.75 4.0740
5a 5 11.25 0.4727 0.49
b 4.5 9.25 0.5054
STUDY 7.
Plasma Fluorescence
Sample No. Volume (ml.) 530 mu 500 mix
la 7 16.0 51.5
b 7 17.5 56
2a 3 32.6 32.3
b 3 29.9 73
3a 3 26.9 59
b 3 25.3 53.3
4a 3 31 63.5
b 7.5 32.2 63.5
5a 3 13.2 53.7
b 3 21 60
6a 3 19.2 53
b 3 16.5 50.6
Reagent blank 10.6 33.35
4 A 50.9 59.25
4 N 20.4 67.5
530 10.075 A + 2.45 N =
500 6.35 A + 3.4125 H = (Factor = 3.434)
5SO 34.59755 A + 3.4125 N =
23.243 A = (530 x 3.434) - 500.
STUDY 7.
Net fluorescence Estimated Mean of the
after subtraction adrenaline duplicate




No. 5&0 mp 500 mp pg/litre pg/litre
la 5.4 17*65 0.0451 0.06
b 6.9 22.15 0.0761
2a 22 46.45 1.1991 1.09
b 19.3 44.15 0.9791
3a 16.3 25.15 1.3640 1.30
b 15.2 24.45 1.2279
4a 20.4 29.65 1.7660 1.63
b 21.6 34.65 1.6656
5a 7.6 19.65 0.2765 0.35
b 10.4 26.15 0.4233
6a 6.6 24.15 0.2361 0.20
b 5*9 16.75 0.1554
STUDY a.
Plasma

































530 5.625 A + 2.0625 N =
500 3.625 A + 6.1375 N = (Factor = 3.00)
530 16.375 A + 6.1375 N =
13.250 A= (530 x 3.0) - 500.
STUDY g
Net fluorescence Estimated Mean of the
after subtraction adrenaline duplicate




No. 5S0 isji 500 TOji jig/litre yug/litre
la 3.25 10 -0.01£9 -0.33
b 19.25 64.5 -O.636S
2a 3.75 •10.5 O.O566 o.oa
b 4.25 11.5 0.1053
3a 15.75 19.0 2.1321 2.15
b 13.75 15.5 2.1593
4a IO.25 9.5 1.603a 1.67
b 10.25 10 1.7400
5a 16.75 19.6 2.3132 2.30
b 20.25 30.5 2.2S30
6a 5.25 11.0 0.35a5 0.36
b 3.75 7.0 0.3564
STUDY 9.
Plasma

































5#Q 6.5625 A + 2.375 N =
500 4.625 A + 7.6S75 N = (Factor = 3.237)
5S0 21.242S A + 7.6S75 N s
16.61S A = (5S0 x 3.237) - 500.
STUDY 9.
Net fluorescence Estimated Mean of the
after subtraction adrenaline duplicate




No, 560 rap 500 cyi pg/litre ^ug/lltre
la 2.25 9.25 -0.1460 -0.19
b 3.75 14.75 -0.2244
2a 6.75 13.75 0.6093 0.66
b 7.75 16.75 0.7167
3a 7.25 14.75 0.7494 0.76
b a.25 17.75 0.7699
4a 6.75 15.75 0.9356 I.05
b 9.75 16.25 1.1443
5a 12.25 23.25 1.2339 1.10
b 9.75 20.25 0.9723
6a 5.75 16.75 -0.0104 -0.03
b 3.75 12.75 -0.0460
Study 10.
Plasma Fluorescence
Sample No. Volume (ml.) 560 mu 500 mu
la S 17.5 52.5
b S 15.5 47.5
2a S 17 47.5
b S 17 47
3a S 19 50.5
b S 20 54.5
4a S 22 57.5
b S 20.2 53
5a s 19 50.5
b s 19.5 52
6a s 26 S3
b s 17.5 53
Reagent blank 14.5 41.4
4 A 50.5 59.9
4 N 27.1 Si.5
5SO 9.0 A + 3.15 N =
500 4.625 A + 10.025 N = (Factor = 3.1S3)
5SO 2S.647 A + 10.025 N =
24.022 A = (5S0 x 3.163) - 500.
STUDY 10
Met fluorescence Estimated Mean of the
after subtraction adrenaline duplicate
of blank values (corrected samples
for plasma
Sample
No. 500 rrp 500 nju pg/litre |ug/litre
la 3.0 11.1 -0.0013 -0.12
b 1.0 6.1 —0.1510
2a 2.5 6.1 0.0966 0.11
b 2.5 5*6 0.1228
3a 4.5 9.1 0.2716 O.25
b 5.5 13.1 0.2293
4a 7.5 16.1 0.4045 0.37
b 5.7 11.6 0.3405
5a 4.5 9.1 0.2710 0.27
b 5.0 10.6 0.2766
6a 11.5 41.6 -0.2599 -0.18




Sample No. Volume (ml.) 5$0 rp 500 np
la 7 16 4g.5
b g 16 43.5
2a 7 20 53
b g 19 49.5
3a 7 19.5 51
b g 23 61
4a 7 19.5 50
b g 21 52
5a 7 20 51
b g 21 52.5
6a 7 17 49
b g 17 4g.5
Reagent blank 13.75 39.5
4 A 49.25 60.75
4 N 25.75 76.75
5gO g.g75 A + 3.00 N =
500 5.3125 A + 9.3125 N = (Factor = 3
5gQ 27.54g A + 9.3125 N =
I * 22.236 A = (5g0 x 3.104)' - 500.
STUDY 11.
Net fluorescence Estimated Mean of the
after subtraction adrenalins duplicate




No. 5S0 rap 500 rap pg/litre jUg/litre
la 2.25 9.0 -0.1296 -0.12
b 2.25 9.0 -0.1134
2a 6.25 13.5 0.3790 0.37
b 5.25 10.0 0.3539
3a 5.75 11.5 0.4079 0.41
b 9.25 21.5 0.4054
4a 5.75 10.5 0.4720 0.52
b 7.25 12.5 0.5624
5a 6.25 11.5 0.5076 0.52
b 7.25 13.0 0.5343
6a 3.25 9.5 -0.0377 -0.05
b 3.25 9.0 -0.0611















































































































































Studies.Within samples 62 1.5595 .0252 - -
TABLE IV. ADRENALINE















































































































































































TABLE VI NORADRENALINE 135.
Source of Sum of Mean
variation DF Squares Square F P
Total 11 27.6673
Between samples 5 23.3724 4.6745 6.52 <C0.05
Within samples 6 4.3049 .7175
Total 12 6.5356
Between samples 6 0.4037 0.0673 Q.07
Within samples 6 6.1319 1.0303
Total 11 6.6569
Between samples 5 3>4249 .6350 1.27
Within samples 6 3.2320 .5337
Total 9 42.1590
Between samples 4 37.0242 9.2561 9.01 ^0.01
Within samples 5 5*1343 1.0270
Total 3 6.5774
Between samples 4 .5464 .1366 0.09
Within samples 4 6.0310 1.5073
Total 9 9.9569
Between samples 4 4.0233 1.0060 0.35
Within samples 5 5.9331 1.1366
Total 11 17.0142
Between samples 5 15.1329 3*0366 9.95 ^0.01
Within samples o 1.3313 .3052
Total 11 132.9749
Between samples 5 61.3701 12.3740 1.04
Within samples 6 71.1043 II.85O6
Total 11 3.O852
Between samples 5 1.0512 .2102 0.62
Within samples 0 2.0340 .3390
Total 11 23.2339
Between samples 5 12.3630 2.4736 1.37
Within samples 6 10.8659 1.8110
Total 11 1.6948
Between samples 5 .7731 .1546 1.01
Within samples 6 .921? .1536
TABLE VII NORADRENALINE
Study No. S.E. M.S.D.
1 t 0.85 2.07
2 t 1.02 2.4&
3 t 0.73 1.80
4 t 1.01 2.60
5 t 1.23 3.41
6 t 1.09 2.80
7 t 0.55 1.35
a t 3.44 #•43
9 t 0.58 1.42
10 t 1.35 3.29































































































































































S.6S75A+ 3.5 N *
3.S75A + 10.5625N =
26.21SSSA + 10.5625 N »































































































5SO 7.5 A ♦ 2.90625 N -
500 3.9375 A + 6.53125 N «
5SO 16.S525 A + 6.53125 N «














la 3.5 19 .0077
b 4.4 3.1 0.1333
2a 5.6 12 0.0452
b 5.3 11.4 0.0394
3a 3.4 3.0 -0.0279
b 1.7 6.0 -0.1376
4a 5.2 3.3 0.2621
b 4.5 7.0 0.2409
5a 12.3 35 -0.5700




















































































































































Benzene Ring - This is a hexagon containing six carbon
atoms to each of which a hydrogen atom is attached.
Substitution of one hydroxyl group produces hydroxy-
benzene (phenol); introduction of two hydroxyl groups







Epinine and Noradrenaline - Page 10






Aromatic polyhydroxy compounds - Derivatives of benzene
(C5H5), containing more than one hydroxyl group.
pH = -log. hydrogen ion concentration = log,
indicating the inverse relationship between
H+ and OH"* in solutions of acids and bases.
H*
145.
6. Ascorbic acid - Vitamin C, one of the group of sub¬
stances known as enediols, which contain two adjacent
carbon atoms linked by a double bond and substituted
with an OH group at each carbon atom. .
7. Basic dissociation constant (K) - see Note 9.
£. Alkalylamines - amines (i.e. containing the group NH£»
substituted or unsubstituted) derived from hydrocarbons
of the general formula CnH2n+3-»
146.
9* Law of Mass Action - The rate at which a substance reacts
is proportional to its active mass (molecular weight
expressed in gins.) and hence the velocity of a chemical teachon
is proportional to the products of the molecular concen¬
trations of the reactants. Thus, in the reaction
A + ii -—* 6 ♦ d, the velocity of the forward reaction is
V = Vf » ^i[a] [b] • The velocity of the backward reaction
is vb « k2[c] [d].
At equilibrium Vf « Vb
or kl[A] [b]- k2 [c] [d] .
hence kl - fC1[D *
k2 [A] [B]
K, the Dissociation Constant.
10. Non-basic polyhydroxy phenol compounds - Non-basic
compounds in which several hydrogen atoms of the benzene
nucleus have been replaced by hydroxyl groups.
Triose - A carbohydrate (monosaccharide) containing 3
carbon atoms. 3 trioses are known - dihydroxyacetone
and 2 stereoisomers of glyceraldehyde•
Diose - A carbohydrate (monosaccharide) containing 2
carbon atoms.
*2. Pentoses and hexoses - Carbohydrates containing 5 and
6 carbon atoms respectively.
13. Ergothioneine - A nitrogenous base, containing sulphur
and present in blood; ergothioneine is found in ergot.
14 (a) Thiols • Hydrosulphide compounds of the type R - SH
i.e., containing the monovalent + radical SH.
(b) Enediols - Substances containing 2 adjacent carbon
atoms linked by a double bond and substituted with an
OH group at each carbon atom, e.g. ascorbic acid (Note
15 (a) Monohvdric phenols - One hydrogen atom in the benaene
nucleus is replaced by a hydroxyl group.
(b) Resorcinol - A bactericide, like phenol in action.
Resorcinol is widely used in ointments for the treatment
of skin conditions.





16. Eserine (physostigraine) - One of several alkaloids
Isolated from the Calabar bean, important pharmaco¬
logically because of its inhibitory activity against
cholinesterase, the physiological enzyme responsible
for the breakdown of acetyl choline. One of the degra¬
dation products of eserine is rubreserine, an ortho-
quinone related in structure to adrenochrome.
3-7• 5N. MaQH - A solution containing 5 x 40 gms. sodium
hydroxide in one litre. A normal solution (N.) contains
one gram-equivalent weight of active substance in
1 litre of solution at 20°C.
IS. Dialysis - The basis of this physical process is the
separation of a colloidal solution from electrolytes by
enclosing the solution in a membrane (e.g. collodion,
parchment paper) which is placed in water. Ultrafiltra¬
tion is a similar process in which a colloidal solution
is filtered under pressure through such a membrane, the
larger molecules being retained by the filter while the
small molecules, together with the solvent, can pass
through.
19. Buffer solution - A solution having reserve acidity and
alkalinity, taking up considerable amounts of acid or
alkali with only slight changes in pH. A buffer is
usually defined as a solution containing a weak acid or
base with one of its salts.
149.
20. Melanin - The brown pigment derived from tyrosine and
produced by oxidation of adrenaline to beyond the stage
reached when the fluorescent compound adrenolutine is
formed (Page 102).
21. Isomeric - Possessing the property of optical isomerism,
i.e. the substance can exist in two forms, dextro and
laevo, which rotate the plane of polarised light to
right and left respectively. The racemie form of a sub¬
stance is a mixture containing equal parts of the d-
and 1- forms.
22. Indoxvl derivatives - Derivatives of 3-hydroxy-indole,
present in animal urine.





24. Ethylene diamine - Page /O^.
25 (a) Tryptophane - One of the essential amino acids, which
gives rise to all the derivatives of indole formed
during protein putrefaction.
(b) Tyrosine - An amino acid concerned in the synthesis
of thyroxine, cf adrenaline and noradrenaline, and
of the pigment melanin.
X"
VH,. CH COOH
26. Ef value - The Rf factor refers to the rate at which a
substance (dissolved in a solvent) advances relative to
the solvent when a solution spreads over a porous material
such as the -cellulose employed for paper chromato¬
graphy, nBy chromatography is meant those processes
which allow the resolution of mixtures by effecting sepa¬
ration of some or all of their components in concentra¬
tion zones on or in phases different from those in which
151.
they are originally present, irrespective of the nature
of the force or forces causing the substance to move
from one phase to another." (Williams, 1954).
27. In the Farrand photoelectric fluorimeter. the light
source is a mercury vapour arc lamp providing ultra¬
violet and visible radiation. Opening the shutter allows
the exciting light beam to pass through a diaphragm
with an aperture of variable size. A quartz lens system
is used to direct the light in parallel rays through
the primary filter on to a glass cuvette with contained
sample for estimation. The fluorescent radiation from
the sample is collected at right angles to the illum¬
inating beam. By means of a second quartz lens system
and secondary filter, the fluorescent beam is used to
image the centre of the cuvette on the cathode of a
photomultiplier tube. The photoelectrical response is
indicated on the attached Rubicon galvanometer.
28, Fick Principle - The general formulas used in the cal¬
culation of cardiac output according to the principle
outlined by Fick are -
C02 output (c.c.)





The Arterio-venous differences are found by determining the
oxygen or carbon dioxide content of arterial blood by arter¬
ial puncture, and of mixed venous blood by withdrawing a
sample through a catheter passed into the right auricle.
(41) Since the classic paper by Oliver and Schaefer
(1S95) who described the pressor effects produced by
intravenous injection of extracts of adrenal gland,
biological methods have been preferred to the less
specific chemical techniques for the assay of adren¬
aline in tissue extracts and body fluids. A detailed
analysis of all the methods of biological assay of
adrenaline is outside the scope of this presentation;
a comprehensive summary of the majority of techniques
which have been used for biological assay of adrenaline
in blood, commencing with Battelli (1902b), is avail¬
able elsewhere (Pekkarinen, 194$)«
In the course of a recent evaluation, Gaddum,
Peart and Vogt (1949) supported the earlier view held
by several workers (Schlossmann, 1927; Kahlson and Werz,
1930; Kure, Okinaka, Ohshima, Shimamota and Okamura, 1936)
that the perfused rabbit ear was a sensitive preparation
for the estimation of adrenaline.. For blood analysis,
however, the most sensitive preparation was considered
to be the rat uterus contracted by acetyl choline (see
also Gaddum and Lembeck, 1949)•
On the basis of parallel quantitative assays,
employing five test preparations (rat uterus, rat colon,
rabbit ear, cat spleen cat nictitating membrane) Gaddum,
Peart and Vogt (1949) described a method for the estima¬
tion of adrenaline and noradrenaline in extracts contain-
ing a mixture of both amines. Application of this tech¬
nique to blood was adversely affected by interfering
substances, however, and the sensitivity of the method,
10 ug. adrenaline, and 100 ug. noradrenaline per litre,
precluded its use for the estimation of normal plasma
samples.
The isolated rectal caecum of the hen (Bergstrom
et al. 1950) and the denervated nictitating membrane of
the cat (Bulbring and Burn, 1949) were incorporated into
parallel methods of biological assay employed by other
workers.
The possibility of accurate biological assay of
adrenaline in blood was considerably increased by the
use of paper chromatography (James, 194&) for the separa¬
tion of adrenaline and noradrenaline in plasma samples
(Crawford and Outschoorn, 1951). After preliminary
extraction of catechol amines by means of acid-ethanol,
and their application to paper, the eluates from the
adrenaline and noradrenaline spots on the chromatograph
paper were assayed separately, using the rat blood
pressure. With this technique, assay of 0.25 ug. adren¬
aline or noradrenaline per ml. could be accomplished,
the loss being 0 to 25%.
From subsequent use of this technique of separa¬
tion of adrenaline and noradrenaline from plasma by
paper chromatography, followed by biological assay of
adrenaline on the rat uterus stimulated by earbachol
(Vogt, 1952; Holzbauer and Vogt, 1954) it appears that
a reliable biological technique is available for the
estimation of adrenaline in plasma. The sensitivity
of Vogt's technique allows greater than 70$ recovery
of 0.4 ug. adrenaline per litre. Satisfactory reco¬
very of 1 ug. noradrenaline per litre is obtainable
by employing the rat blood pressure. The procedure is
a formidable one, however, ana its use may tend to be
limited to a few special centres where adequate exper¬
ience and facilities are available.
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